# EDGAR Filing Document

**Accession Number:** 0001741600
**File Stem:** 0001193125-23-004840
**Filing Date:** 2023-1
**Character Count:** 133292
**Document Hash:** 7943a15344cfba6e9da7735f241822f7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-004840.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0001193125-23-004840

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 10

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Multi-Sector Opportunities Trust II
- **CENTRAL INDEX KEY:** 0001741600
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91550
- **FILM NUMBER:** 23518859

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
- **BUSINESS PHONE:** (800) 882-0052

**MAIL ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock Multi-Sector Opportunities Trust II
- **CENTRAL INDEX KEY:** 0001741600
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
- **BUSINESS PHONE:** (800) 882-0052

**MAIL ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809

**As filed with the Securities and Exchange Commission on January 9, 2023** 

------

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**SCHEDULE TO** 

------

**TENDER OFFER STATEMENT** 

**Under Section 14(d)(1) or 13(e)(1)** 

**of the Securities Exchange Act of 1934** 

------

## BlackRock Multi-Sector Opportunities Trust II
**(Name of Subject Company (Issuer))** 

**(Names of Filing Person(s) (Issuer))** 

**Common Shares of Beneficial Interest, Par Value $0.001 per share** 

**(Title of Class of Securities)** 

**09258V101** 

**(CUSIP Number of Class of Securities)** 

**John M. Perlowski** 

**BlackRock Multi-Sector Opportunities Trust II** 

**55 East 52nd Street** 

**New York, New York 10055** 

**1-800-441-7762** 

**(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person(s))** 

------

***Copies to:***

---

| | |
|:---|:---|
| **Margery K. Neale, Esq.** | **Janey Ahn, Esq.** |
| **Willkie Farr & Gallagher LLP** | **BlackRock Advisors, LLC** |
| **787 Seventh Avenue** | **55 East 52nd Street** |
| **New York, New York 10019** | **New York, New York 10055** |

---

------

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which this statement relates:

☐ third-party tender offer subject to Rule 14d-1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ issuer tender offer subject to Rule 13e-4

☐ going-private transaction subject to Rule 13e-3

☐ amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer. ☐

------

**Introductory Statement** 

This Issuer Tender Offer Statement on Schedule TO relates to an offer by BlackRock Multi-Sector Opportunities Trust II, a Delaware statutory trust (the "Trust"), to repurchase 5% of its issued and outstanding common shares of beneficial interest as of January 3, 2023, par value $0.001 per share (the "Shares"), in exchange for cash at a price equal to the net asset value ("NAV") per Share (the "Purchase Price") determined as of the close of the regular trading session of the New York Stock Exchange (the "NYSE") on the day the offer expires (the "Pricing Date"), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 9, 2023 (the "Offer to Purchase"), and in the related Tender Request Form which are filed as exhibits to this Schedule TO.

This Issuer Tender Offer Statement on Schedule TO is being filed in satisfaction of the reporting requirements of Rule 13e-4(c)(2) promulgated under the Securities Exchange Act of 1934, as amended.

The information set forth in the Offer to Purchase and the related Tender Request Form is incorporated herein by reference in answer to Item 1 through Item 9 and Item 11 of Schedule TO.

**Item 1.** **Summary Term Sheet** <br>

The information set forth under "Summary Term Sheet" in the Offer to Purchase is incorporated herein by reference.

**Item 2.** **Subject Company Information** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The name of the issuer is BlackRock Multi-Sector Opportunities Trust II, a diversified closed-end management investment company, organized as a Delaware statutory trust (the "Trust"). The principal executive offices of the Trust are located at 100 Bellevue Parkway, Wilmington, Delaware 19809. The telephone number of the Trust is (800) 882-0052.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The title of the securities being sought is common shares of beneficial interest, par value $0.001 per share. As of January 3, 2023, there were 1,249,010 Shares issued and outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There is no established trading market for the Shares.

**Item 3.** **Identity and Background of Filing Person** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Trust is the filing person. BlackRock Advisors, LLC acts as the investment adviser for the Trust (the "Investment Advisor"). The Investment Advisor, located at 100 Bellevue Parkway, Wilmington, Delaware 19809, is a wholly-owned subsidiary of BlackRock, Inc. The members of the Trust's Board of Trustees are Cynthia L. Egan, Frank J. Fabozzi, Lorenzo A. Flores, Stayce D. Harris, J. Phillip Holloman, R. Glenn Hubbard, W. Carl Kester, Catherine A. Lynch, Robert Fairbairn and John M. Perlowski (each, a "Trustee"). The principal executive officer and principal financial and accounting officer of the Trust are John M. Perlowski and Trent Walker, respectively. The Trustees and the executive officers of the Trust may be reached at the Trust's business address and phone number set forth in Item 2(a) above. The information set forth in the Offer to Purchase under "Certain Information about the Trust" is incorporated herein by reference.

**Item 4.** **Terms of the Transaction** <br>

(a)(1) The following sections of the Offer to Purchase contain a description of the material terms of the transaction and are incorporated herein by reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Summary Term Sheet"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Price; Number of Shares"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Purpose of the Offer"

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Plans or Proposals of the Trust"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Certain Conditions of the Offer"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Procedures for Tendering Shares for Purchase"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Withdrawal Rights"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Payment for Shares"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Source and Amount of Consideration"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Effects of the Offer; Consequences of Participation"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Interests of Trustees and Officers; Transactions and Arrangement Concerning the Shares"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Certain Information about the Trust"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Certain U.S. Federal Income Tax Consequences"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Amendments; Extensions of Repurchase Period; Termination"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Fees and Expenses"

(a)(2) Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The information set forth in the Offer to Purchase under "Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares" is incorporated herein by reference.

**Item 5.** **Past Contracts, Transactions, Negotiations and Agreements** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The information set forth in the Offer to Purchase under "Purpose of the Offer;" "Plans or Proposals of the Trust," "Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares" and "Certain Information about the Trust" is incorporated herein by reference.

**Item 6.** **Purposes of the Transaction and Plans or Proposals** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The information set forth in the Offer to Purchase under "Purpose of the Offer" and "Plans or Proposals of the Trust" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The information set forth in the Offer to Purchase under "Purpose of the Offer" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The information set forth in the Offer to Purchase under "Purpose of the Offer" and "Plans or Proposals of the Trust" is incorporated herein by reference.

**Item 7.** **Source and Amount of Funds or Other Considerations** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The information set forth in the Offer to Purchase under "Source and Amount of Consideration" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The information set forth in the Offer to Purchase under "Source and Amount of Consideration" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The information set forth in the Offer to Purchase under "Source and Amount of Consideration" is incorporated herein by reference.

**Item 8.** **Interests in Securities of the Subject Company** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The information set forth in the Offer to Purchase under "Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares" is incorporated herein by reference.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The information set forth in the Offer to Purchase under "Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares" is incorporated herein by reference.

**Item 9.** **Persons/Assets Retained, Employed, Compensated or Used** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) No persons have been directly or indirectly employed, retained, or are to be compensated by or on behalf of the Trust to make solicitations or recommendations in connection with the Offer to Purchase.

**Item 10.** **Financial Statements** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The audited annual financial statements of the Trust dated December 31, 2021 and the schedule of investments of the Trust dated December 31, 2021, both filed with the SEC on EDGAR on Form N-CSR on March 4, 2022, are incorporated by reference. The unaudited semi-annual financial statements of the Trust dated June 30, 2022 and the schedule of investments of the Trust dated June 30, 2022, both filed with the SEC on EDGAR on Form N-CSR on September 1, 2022, are incorporated by reference. The Trust will prepare and transmit to shareholders the audited annual financial statements of the Trust and the schedule of investments of the Trust within 60 days after the close of the period for which the report is being made, or as otherwise required by the Investment Company Act of 1940.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Not applicable.

**Item 11.** **Additional Information** <br>

(a)(1) The information set forth in the Offer to Purchase under "Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares" is incorporated herein by reference.

(a)(2) None.

(a)(3) Not applicable.

(a)(4) Not applicable.

(a)(5) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Not applicable.

---

| | |
|:---|:---|
| **Item 12(a).** | **Exhibits**  |

---

---

| | |
|:---|:---|
| (a)(1)(i) | [Offer to Purchase, dated January 9, 2023 is filed herewith.](d419816dex99a1i.htm) |
| (a)(1)(ii) | [Form of Tender Request Form is filed herewith.](d419816dex99a1ii.htm) |
| (a)(2) | None. |
| (a)(3) | Not Applicable. |
| (a)(4) | Not Applicable. |
| (a)(5)(i) | [Press release issued on January 3, 2023 is incorporated by reference to the Trust's Schedule TO-C, as filed with the SEC on January 3, 2023.](http://www.sec.gov/Archives/edgar/data/1741600/000119312523000824/d639669dsctoc.htm) |
| (b) | None. |
| (d)(1) | [Form of Automatic Dividend Reinvestment Plan is incorporated by reference to Pre-Effective Amendment No. 2 to the Trust's Registration Statement on Form N-2, as filed with the SEC on November 5, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518318382/d567486dex99e.htm) |
| (d)(2) | [Form of Investment Management Agreement between the Trust and BlackRock Advisors, LLC is incorporated by reference to Pre-Effective Amendment No. 1 to the Trust's Registration Statement on Form N-2, as filed with the SEC on September 4, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518266361/d567486dex99g1.htm) |

---

------

---

| | |
|:---|:---|
| (d)(3) | [Form of Amended and Restated Sub-Investment Advisory Agreement between BlackRock Advisors, LLC and BlackRock International Limited is incorporated by reference to the Trust's Schedule TO-I, as filed with the SEC on July 9, 2020.](http://www.sec.gov/Archives/edgar/data/1741600/000119312520190477/d61212dex99d3.htm) |
| (d)(4) | [Form of Sub-Investment Advisory Agreement between BlackRock Advisors, LLC and BlackRock (Singapore) Limited is incorporated by reference to Pre-Effective Amendment No. 1 to the Trust's Registration Statement on Form N-2, as filed with the SEC on September 4, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518266361/d567486dex99g4.htm) |
| (d)(5) | [Form of BlackRock Fixed-Income Complex Third Amended and Restated Deferred Compensation Plan is incorporated by reference to Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2 of BlackRock Credit Strategies Fund (File No. 333-227456), as filed with the SEC on January 16, 2019.](http://www.sec.gov/Archives/edgar/data/1752019/000119312519010696/d625057dex99i.htm) |
| (d)(6) | [Transfer Agency and Shareholder Services Agreement is incorporated by reference to the Trust's Schedule TO-I, as filed with the SEC on July 9, 2020.](http://www.sec.gov/Archives/edgar/data/1741600/000119312520190477/d61212dex99d6.htm) |
| (d)(7) | [Form of Amendment to Transfer Agency and Shareholder Services Agreement is incorporated by reference to Pre-Effective Amendment No. 2 to the Trust's Registration Statement on Form N-2, as filed with the SEC on November 5, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518318382/d567486dex99k1b.htm) |
| (d)(8) | [Form of Administration and Accounting Services Agreement is incorporated by reference to Pre-Effective Amendment No. 2 to the Trust's Registration Statement on Form N-2, as filed with the SEC on November 5, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518318382/d567486dex99k2.htm) |
| (d)(9) | [Form of Custody Agreement is incorporated by reference to Pre-Effective Amendment No. 2 to the Trust's Registration Statement on Form N-2, as filed with the SEC on November 5, 2018.](http://www.sec.gov/Archives/edgar/data/1741600/000119312518318382/d567486dex99j.htm) |
| (g) | None. |
| (h) | None. |

---

---

| | |
|:---|:---|
| **Item 12(b).** | **Filing Fees**  |

---

[Filing Fee Exhibit.](d419816dexfilingfees.htm)

**Item 13.** **Information Required By Schedule 13E-3** <br>

Not Applicable.

------

**SIGNATURE** 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | |
|:---|:---|
|  **BlackRock Multi-Sector Opportunities Trust II** | **BlackRock Multi-Sector Opportunities Trust II** |
| By: | /s/ John M. Perlowski |
|  | Name: John M. Perlowski |
|  | Title: President and Chief Executive Officer |
|  | Dated: January 9, 2023 |

---

------

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
|  (a)(1)(i) | [Offer to Purchase, dated January 9, 2023.](d419816dex99a1i.htm) |
|  (a)(1)(ii) | [Form of Tender Request Form.](d419816dex99a1ii.htm) |
|  | [Filing Fee Exhibit.](d419816dexfilingfees.htm) |

---

## Ex-99.(A)(1)(I)

##### [**Table of Contents**](#toc)
**Exhibit (a)(1)(i)** 

**Offer to Purchase** 

**Up to 5% of the Issued and Outstanding Common Shares of Beneficial Interest** 

**of** 

**BlackRock Multi-Sector Opportunities Trust II** 

**at** 

**Net Asset Value Per Share** 

**by** 

**BlackRock Multi-Sector Opportunities Trust II** 

**in Exchange for Cash** 

**THE OFFER TO PURCHASE WILL EXPIRE AT 4:00 P.M., EASTERN TIME,** 

**ON FEBRUARY 8, 2023, UNLESS THE OFFER IS EXTENDED.** 

To the Common Shareholders of BlackRock Multi-Sector Opportunities Trust II:

BlackRock Multi-Sector Opportunities Trust II, a diversified, closed-end management investment company, organized as a Delaware statutory trust (the "Trust"), is offering to purchase up to 5% of its issued and outstanding common shares of beneficial interest as of January 3, 2023, par value $0.001 per share (the "Shares") (the "Offer Amount"). The offer is to purchase Shares in exchange for cash at a price equal to the net asset value ("NAV") per Share (the "Purchase Price") determined as of the close of the regular trading session of the New York Stock Exchange (the "NYSE") on the day the offer expires (the "Pricing Date"). The offer is being made upon the terms and subject to the conditions set forth in this Offer to Purchase and the related Tender Request Form (in the case of shareholders who hold their account directly with BlackRock) (which, together with any amendments or supplements thereto, collectively constitute the "Offer"). If more than the Offer Amount is tendered and not withdrawn, any purchases will be made on a pro rata basis.

In order to participate, the materials described in the Offer must be delivered to BNY Mellon Investment Servicing (US), Inc. (the "Transfer Agent") by 4:00 p.m. Eastern time, February 8, 2023, or such later date to which the Offer is extended (the "Expiration Date"). Should the Offer be extended beyond February 8, 2023, the Pricing Date will be the close of ordinary trading on the NYSE on the newly designated Expiration Date. Shareholders who choose to participate in the Offer can expect payments for Shares tendered and accepted to be mailed within approximately ten business days after the Expiration Date.

As of January 3, 2023, the Trust had 1,249,010 Shares outstanding (rounded to the nearest whole Share) and its NAV per Share was $69.84. The NAV on the Pricing Date may be higher or lower than the NAV as of January 3, 2023. For the Trust's most current NAV, you may view online at https://www.blackrock.com/us/individual/products/308034/. **For additional questions or information during the pendency of this Offer, you may contact your financial adviser, broker/dealer or other financial intermediary which holds your shares. If your account is held directly at BlackRock, you may contact the Trust at 1-800-882-0052, Option 4.**

**The Offer is subject to important terms and conditions, including the conditions listed under Section 4, "Certain Conditions of the Offer."** 

**Neither the Securities and Exchange Commission (the "Commission") nor any state securities commission has approved or disapproved of the Offer, passed upon the fairness or merits of the Offer, or determined whether this Offer to Purchase is accurate or complete. Any representation to the contrary is a crime.** 

**If you are not interested in selling any of your Shares at this time, you do not need to do anything. This Offer is not part of a plan to liquidate the Trust. Shareholders are not required to participate in the Offer.** 

------

##### [**Table of Contents**](#toc)
**You should be aware that, if you tender Shares pursuant to the Offer, tendered Shares will not be entitled to receive any Trust dividend or distribution with a record date on or after February 10, 2023.** 

**Because this Offer is limited as to the number of Shares that the Trust will purchase, not all Shares tendered for purchase by shareholders may be accepted for payment by the Trust. This may occur, for example, if one or more large investors seek to tender a significant number of Shares or if a large number of investors tender Shares.** 

**IMPORTANT INFORMATION** 

If you would like to participate in the Offer and have a direct shareholder account held with the Trust (*i.e.*, you receive account statements directly from BlackRock), please complete, sign and date the accompanying Tender Request Form. In order to process your request, it must be received in good order by the Transfer Agent, at P.O. Box 9819, Providence, RI 02940, prior to the Expiration Date. Delivery to an address other than that shown above does not constitute valid delivery.

If you would like to participate in the Offer and your shares are held through a financial intermediary, financial adviser, broker/dealer or other nominee ("Financial Intermediary"), please ask your financial adviser, broker/dealer or other financial intermediary to submit a repurchase request for you. You may be charged a transaction fee for this service by your financial adviser, broker/dealer or other financial intermediary. Please consider broker/dealer processing time that may be needed prior to the Expiration Date.

The Trust reserves the absolute right to reject Shares determined not to be tendered in appropriate form.

**Beneficial owners should be aware that their Financial Intermediary may establish its own earlier deadline for participation in the Offer. Accordingly, beneficial owners wishing to participate in the Offer should contact their Financial Intermediary as soon as possible in order to determine the times by which such owner must take action in order to participate in the Offer.** 

**Neither the Trust nor its Board of Trustees (the "Board of Trustees" or the "Board") nor BlackRock Advisors, LLC (the "Investment Advisor") makes any recommendation to any shareholders as to whether to tender Shares for purchase or to refrain from tendering Shares in the Offer. No person has been authorized to make any recommendation on behalf of the Trust, its Board of Trustees or the Investment Advisor as to whether shareholders should tender Shares for purchase pursuant to the Offer or to make any representation or to give any information in connection with the Offer other than as contained herein. If made or given, any such recommendation, representation or information must not be relied upon as having been authorized by the Trust, its Board of Trustees or the Investment Advisor. Shareholders are urged to carefully evaluate all information in the Offer, consult their own investment and tax advisers and make their own decisions whether to tender their Shares for purchase or refrain from participating in the Offer.** 

**The Trust has filed with the Commission a Tender Offer Statement on Schedule TO under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), relating to the Offer.** 

**The making of the Offer may, in some jurisdictions, be restricted or prohibited by applicable law. The Offer is not being made, directly or indirectly, in or into, and may not be accepted from within, any jurisdiction in which the making of the Offer or the acceptance of the Offer would, absent prior registration, filing or qualification under applicable laws, not be in compliance with the laws of that jurisdiction. Accordingly, shareholders are required to inform themselves of and observe any such restrictions.** 

------

##### [**Table of Contents**](#toc)
**TABLE OF CONTENTS** 

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
|  [SUMMARY TERM SHEET](#toc419816_1) | [SUMMARY TERM SHEET](#toc419816_1) | i |
| 1. | [Price; Number of Shares](#toc419816_2) | 1 |
| 2. | [Purpose of the Offer](#toc419816_3) | 2 |
| 3. | [Plans or Proposals of the Trust](#toc419816_4) | 2 |
| 4. | [Certain Conditions of the Offer](#toc419816_5) | 3 |
| 5. | [Procedures for Tendering Shares for Purchase](#toc419816_6) | 4 |
| 6. | [Withdrawal Rights](#toc419816_7) | 6 |
| 7. | [Payment for Shares](#toc419816_8) | 7 |
| 8. | [Source and Amount of Consideration](#toc419816_9) | 7 |
| 9. | [Effects of the Offer; Consequences of Participation](#toc419816_10) | 7 |
| 10. | [Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares](#toc419816_11) | 9 |
| 11. | [Certain Information about the Trust](#toc419816_12) | 11 |
| 12. | [Additional Information](#toc419816_13) | 11 |
| 13. | [Certain U.S. Federal Income Tax Consequences](#toc419816_14) | 11 |
| 14. | [Certain Legal and Regulatory Matters](#toc419816_15) | 15 |
| 15. | [Amendments; Extensions of Purchase Period; Termination](#toc419816_16) | 15 |
| 16. | [Fees and Expenses](#toc419816_17) | 16 |
| 17. | [Miscellaneous](#toc419816_18) | 16 |
|  [FINANCIAL STATEMENTS](#toc419816_19) | [FINANCIAL STATEMENTS](#toc419816_19) | 17 |

---

------

##### [**Table of Contents**](#toc)
**SUMMARY TERM SHEET** 

*This Summary Term Sheet highlights certain information concerning this Offer. To understand the Offer fully and for a more complete discussion of its terms and conditions, you should read carefully the entire Offer to Purchase and the related Tender Request Form. We have included section references parenthetically to direct you to a more complete description in the Offer of the topics in this Summary Term Sheet.*

**What is the Offer?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Trust is offering to purchase up to 5% of its Shares. The Trust will pay cash for Shares purchased pursuant
to the Offer. The Trust will purchase Shares at a price equal to the NAV per Share as of the close of the regular trading session of the NYSE on the Pricing Date. If the number of Shares properly tendered and not withdrawn prior to the date and time
the Offer expires is less than or equal to the Offer Amount, the Trust will, upon the terms and subject to the conditions of the Offer, purchase all Shares tendered. If shareholders tender (and do not timely withdraw) more than the Offer Amount, the
Trust will purchase duly tendered Shares from participating shareholders on a pro rata basis, based upon the number of Shares each shareholder tenders for purchase and does not timely withdraw. The Trust does not intend to increase the number of
Shares that it is offering to purchase, even if shareholders tender more than the Offer Amount. Shareholders cannot be assured that all of their tendered Shares will be purchased. (See Section 1, "Price; Number of Shares" and
Section 7, "Payment for Shares.")

**When will the Offer expire, and may the Offer be extended?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Offer will expire at 4:00 p.m., Eastern time, on February 8, 2023, the Expiration Date, unless extended.
The Trust may extend the offer period at any time. If it does, the Trust will determine the purchase price as of the close of ordinary trading on the NYSE on the new Expiration Date. The Trust may extend the period of time the Offer will be open by
issuing a press release or making some other public announcement by no later than 9:00 a.m. Eastern time on the next business day after the Offer otherwise would have expired. (See Section 1, "Price; Number of Shares.")

**What is the purpose of the Offer?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In recognition that a secondary market for the Shares does not exist, until the adoption of a plan of
liquidation, the Trust intends, but is not obligated, to conduct quarterly tender offers for up to 5% of the Shares then outstanding in the sole discretion of the Trust's Board of Trustees. On January 3, 2023, the Trust announced that it
intended to repurchase 5% of the Shares outstanding by conducting the Offer. (See Section 2, "Purpose of the Offer" and Section 3, "Plans or Proposals of the Trust.")

**Will I have to pay anything to participate in the Offer?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Trust will not charge a separate service fee in conjunction with the Offer. If your Shares are held through a
Financial Intermediary, the Financial Intermediary may charge a service fee for participation in the Offer. (See Section 1, "Price; Number of Shares," Section 7, "Payment for Shares" and Section 16, "Fees and
Expenses.")

**What is the NAV per Share as of a recent date?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On January 3, 2023, the NAV per Share was $69.84. The NAV on the Pricing Date may be higher or lower than
the NAV as of January 3, 2023. For the Trust's most current NAV, you may view online at https://www.blackrock.com/us/individual/products/308034/. **For additional questions or information during the pendency of this Offer, you may contact your financial adviser, broker/dealer or other financial intermediary which holds your shares. If your account is held directly at BlackRock, you may contact the Trust at 1-800-882-0052, Option 4.** 

i

------

##### [**Table of Contents**](#toc)
**Will the Trust's NAV per Share be higher or lower on the Pricing Date?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No one can accurately predict what the Trust's NAV per Share will be at any future date, including the
Pricing Date. You should realize that the NAV on the Pricing Date may be higher or lower than the NAV as of January 3, 2023 set forth above.

**Does the Trust have the financial resources to pay me for my Shares?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Yes. If the Trust purchased 62,451 Shares (5% of the Shares outstanding as of January 3, 2023, rounded to
the nearest whole Share) at a price per share of $69.84, equal to the NAV as of January 3, 2023, the Trust's total cost, not including fees and expenses incurred in connection with the Offer, would be approximately $4.36 million. The
Trust intends to first use cash on hand to pay for Shares tendered, and then intends to sell portfolio securities to raise any additional cash needed for the purchase of Shares. Other than potentially through the use of reverse repurchase
agreements, the Trust has no intention to borrow money to finance the purchase of Shares in the Offer. (See Section 8, "Source and Amount of Consideration.")

**How do I participate in the Offer?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If your shares are held through a Financial Intermediary, please ask your financial adviser, broker/dealer or
other financial intermediary to submit a tender request for you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• All other shareholders wishing to participate in the Offer must, prior to the date and time the Offer expires,
complete, sign and date a Tender Request Form. You must send these materials to the Transfer Agent at P.O. Box 9819, Providence, RI 02940, prior to the Expiration Date.

**Must I tender all of my Shares for purchase?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• <u>No</u>. You may tender for purchase all or part of the Shares you own. (See Section 1, "Price;
Number of Shares.")

**May I withdraw my Shares after I have tendered them for purchase and, if so, by when?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Yes, you may withdraw all, but not less than all, of your tendered Shares at any time prior to 4:00 p.m., Eastern
time, on February 8, 2023, which is the Expiration Date. (See Section 6, "Withdrawal Rights.")

**How do I withdraw previously tendered Shares?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If your Shares are held at your Financial Intermediary, you may withdraw your tendered Shares prior to the
Expiration Date by submitting notice to your Financial Intermediary. In the event you decide to modify or withdraw your tender, you should provide your Financial Intermediary with sufficient notice prior to the Expiration Date. If you have a direct
shareholder account held with the Trust, tender requests submitted pursuant to the Offer may be modified or withdrawn at any time prior to the Expiration Date by submitting notice to the Transfer Agent at the address indicated in the Tender Request
Form, and the Transfer Agent must receive the notice before the Expiration Date. You may resubmit withdrawn Shares by following the purchase procedures before the Offer expires, including during any extension period. (See Section 6,
"Withdrawal Rights.")

**May my Financial Intermediary place any conditions on my tender of Shares?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No.

**May I place any conditions on my tender of Shares?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No.

ii

------

##### [**Table of Contents**](#toc)
**Is my tender of Shares in the Offer a taxable transaction?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• It is anticipated that the tender of Shares in exchange for cash will generally be a taxable transaction for U.S.
federal income tax purposes either in the form of a "sale or exchange" or, under certain circumstances, a "dividend." Please consult your tax adviser regarding your individual tax consequences, including potential state, local
and foreign tax consequences. (See Section 13, "Certain U.S. Federal Income Tax Consequences.")

**Is there any reason Shares tendered by me for purchase would not be accepted?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In addition to those circumstances described under "Certain Conditions of the Offer" in which the Trust
is not required to purchase tendered Shares, the Trust has reserved the right to reject any and all tendered Shares determined by the Trust not to have been tendered in the appropriate form. For example, tenders will be rejected if the tender does
not include the original signature(s) or the original of any required signature guarantee(s). Moreover, as further described herein, if more than the Offer Amount is tendered and not withdrawn, any purchases will be made on a pro rata basis.

**What should I do if I decide not to tender my Shares for purchase?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• <u>Nothing.</u> There are no actions that you need to take if you determine not to participate in the Offer.

**If I decide not to tender, how will the Offer affect my Shares?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If you do not tender your Shares (or if you own Shares following completion of the Offer), you will be subject to
any increased risks associated with the reduction in the Trust's total assets due to the payment for the tendered Shares. These risks may include greater volatility due to decreased diversification and proportionately higher expenses due to a
decreased asset base, as well as the possibility of receiving additional taxable capital gains on the distributions of the sale of portfolio securities to pay for tendered shares. The reduced assets of the Trust as a result of the Offer may result
in less investment flexibility for the Trust, depending on the number of Shares purchased, could limit the Trust's ability to use leverage and may have an adverse effect on the Trust's investment performance. The Trust currently utilizes
leverage through reverse repurchase agreements. In an effort to maintain the Trust's current asset coverage, the Trust may need to de-lever. This de-levering may
result in decreased returns to the Trust and increased expenses for remaining shareholders. (See Section 9, "Effects of the Offer; Consequences of Participation" and Section 16, "Fees and Expenses.")

**Does the Trust's management recommend that shareholders participate in the Offer, and will management participate in the Offer?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• None of the Trust, the Board of Trustees nor the Investment Advisor is making any recommendation to shareholders
regarding whether to tender Shares for purchase or refrain from tendering Shares in the Offer. The Trust has been advised that neither its Board of Trustees nor officers intend to tender any Shares pursuant to the Offer. (See Section 10,
"Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares.")

**Will there be additional opportunities to tender my Shares to the Trust?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No other tender offers have been approved by the Board, but the Board reserves the right to approve (and the
Trust intends to conduct) tender offers in the future. (See Section 2, "Purpose of the Offer" and Section 3, "Plans or Proposals of the Trust.")

**How do I obtain more information?** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For additional questions or information during the pendency of this Offer, you may contact your financial
adviser, broker/dealer or other financial intermediary which holds your shares. If your account is held directly at BlackRock, you may contact the Trust at 1-800-882-0052, Option 4.

iii

------

##### [**Table of Contents**](#toc)
**1.** **Price; Number of Shares.** 

Upon the terms and subject to the conditions of the Offer (including, if the Offer is extended or amended, the terms and conditions of any such extension or amendment), the Trust will accept for purchase, and pay for, an aggregate amount of up to 5% of its Shares outstanding as of January 3, 2023 that are properly tendered and not timely withdrawn in accordance with Section 6 prior to the Expiration Date. As of January 3, 2023, there were 1,249,010 Shares outstanding (rounded to the nearest whole Share). The term "Expiration Date" means 4:00 p.m., Eastern time, on February 8, 2023, unless the Trust, in its sole discretion, extends the period during which the Offer is open, in which case "Expiration Date" shall mean the time and date on which the Offer, as so extended by the Trust, shall expire. The Trust reserves the right in its sole discretion and for any reason to amend, extend or terminate the Offer prior to the time the Offer expires. See Section 15, "Amendments; Extensions of Purchase Period; Termination." The Trust will not be obligated to purchase Shares pursuant to the Offer under certain circumstances. See Section 4, "Certain Conditions of the Offer."

The purchase price of the Shares will be the NAV per Share determined as of the close of the regular trading session of the NYSE on the Pricing Date. On January 3, 2023, the NAV per Share was $69.84. The NAV on the Pricing Date may be higher or lower than the NAV as of January 3, 2023. For the Trust's most current NAV, you may view online at https://www.blackrock.com/us/individual/products/308034/. **For additional questions or information during the pendency of this Offer, you may contact your financial adviser, broker/dealer or other financial intermediary which holds your shares. If your account is held directly at BlackRock, you may contact the Trust at 1-800-882-0052, Option 4.** Shareholders tendering Shares shall be entitled to receive all dividends with an "ex date" on or before the Expiration Date provided that they own Shares as of the record date for such dividend. Shareholders should be aware that, if they tender Shares pursuant to the Offer, tendered Shares will not be entitled to receive any Trust dividend or distribution with a record date on or after February 10, 2023.

The Offer is being made to all shareholders and is not conditioned upon shareholders tendering for purchase in the aggregate any minimum number of Shares. If the number of Shares properly tendered and not withdrawn prior to the date and time the Offer expires is less than or equal to the Offer Amount, the Trust will, upon the terms and subject to the conditions of the Offer, purchase all Shares tendered. If more than the Offer Amount is duly tendered for purchase pursuant to the Offer (and not timely withdrawn as provided in Section 6), the Trust, subject to the conditions listed in Section 3, will purchase Shares from participating shareholders in accordance with the terms and conditions specified in the Offer on a pro rata basis based upon the number of Shares duly tendered (and not timely withdrawn) by or on behalf of each shareholder. The Trust does not intend to increase the number of Shares offered for purchase, even if more than the Offer Amount is tendered by all shareholders in the aggregate.

The Trust currently utilizes leverage through reverse repurchase agreements. As of December 31, 2022, this leverage represented approximately 14.53% of the Trust's Managed Assets (approximately 17.01% of the Trust's net assets). "Managed Assets" means the total assets of the Trust (including any assets attributable to reverse repurchase agreements) minus the sum of the Trust's accrued liabilities (other than borrowings representing financial leverage). The Trust intends to maintain approximately the same level of economic leverage, as a percentage of Managed Assets, following the Offer. Based on the number of Shares purchased in the Offer, the Trust may reduce its use of reverse repurchase agreements in order to maintain the Trust's overall economic leverage targets.

The Trust will not charge a separate service fee in conjunction with the Offer. If your Shares are held through a Financial Intermediary, the Financial Intermediary may charge a service fee for participation in the Offer. Tendering shareholders will not be obligated to pay transfer taxes on the purchase of Shares by the Trust, except in the circumstances set forth in Section 7, "Payment for Shares."

------

##### [**Table of Contents**](#toc)
On January 3, 2023, there were 1,249,010 Shares issued and outstanding (rounded to the nearest whole Share). The Trust has been advised that neither its Board of Trustees nor officers intend to tender any Shares pursuant to the Offer.

The Trust reserves the right, in its sole discretion, at any time or from time to time, to extend the period of time during which the Offer is open by giving notice of such extension to the Transfer Agent and making a public announcement thereof. See Section 15, "Amendments; Extensions of Purchase Period; Termination." The Trust makes no assurance that it will extend the Offer. During any extension, all Shares previously tendered and not withdrawn will remain subject to the Offer, subject to the right of a tendering shareholder to withdraw his or her Shares.

**2.** **Purpose of the Offer.** 

In recognition that a secondary market for the Shares does not exist, until the adoption of a plan of liquidation, the Trust intends, but is not obligated, to conduct quarterly tender offers for up to 5% of the Shares then outstanding in the sole discretion of the Trust's Board of Trustees. On November 11, 2022, the Board approved the Offer.

Any Shares purchased by the Trust pursuant to the Offer will be available for issuance by the Trust without further shareholder action (except as required by applicable law).

None of the Trust, the Board nor the Investment Advisor makes any recommendation to any shareholder as to whether to tender Shares for purchase or to refrain from tendering Shares in the Offer. No person has been authorized to make any recommendation on behalf of the Trust, the Board or the Investment Advisor as to whether shareholders should tender Shares for purchase pursuant to the Offer or to make any representation or to give any information in connection with the Offer other than as contained herein. If made or given, any such recommendation, representation or information must not be relied upon as having been authorized by the Trust, the Board or the Investment Advisor. Shareholders are urged to evaluate carefully all information in the Offer, consult their own investment and tax advisers and make their own decisions whether to tender their Shares for purchase or refrain from participating in the Offer.

**3.** **Plans or Proposals of the Trust.** 

Except to the extent described herein or in connection with the operation of the Trust's automatic dividend reinvestment plan, the Trust does not have any present plans or proposals and is not engaged in any negotiations that relate to or would result in:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any extraordinary transaction, such as a merger, reorganization or liquidation, involving the Trust or any of its subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) other than in connection with transactions in the ordinary course of the Trust's operations and for purposes of funding the Offer, any purchase, sale or transfer of a material amount of assets of the Trust or any of its subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any material change in the Trust's present dividend policy, or indebtedness or capitalization of the Trust;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) changes to the present Board or management of the Trust, including changes to the number or the term of members of the Board, the filling of any existing vacancies on the Board or changes to any material term of the employment contract of any executive officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any other material change in the Trust's corporate structure or business, including any plans or proposals to make any changes in the Trust's investment policy for which a vote would be required by Section 13 of the 1940 Act;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) any class of equity securities of the Trust being delisted from a national securities exchange or ceasing to be authorized to be quoted in an automated quotations system operated by a national securities association;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) any class of equity securities of the Trust becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) the suspension of the Trust's obligation to file reports pursuant to Section 15(d) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the acquisition by any person of additional securities of the Trust, or the disposition of securities of the Trust (other than through periodic purchase offers by the Trust, including this Offer); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) any changes in the Trust's Agreement and Declaration of Trust, Bylaws or other governing instruments or other actions that could impede the acquisition of control of the Trust.

**4.** **Certain Conditions of the Offer.** 

Notwithstanding any other provision of the Offer, and in addition to (and not in limitation of) the Trust's right to extend, amend or terminate the Offer at any time in its sole discretion, the Trust shall not be required to accept for purchase or, subject to the applicable rules and regulations of the Commission, including Rule 14e-1(c) under the Exchange Act, pay for, and may delay the acceptance of or payment for, any tendered Shares, if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) such transactions, if consummated, would

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) impair the Trust's status as a regulated investment company ("RIC") under the U.S. federal
income tax laws (which would cause the Trust's income to be taxed at the corporate level in addition to the taxation of shareholders who receive dividends from the Trust); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) result in the Trust's asset coverage with respect to any indebtedness or preferred equity being reduced
below the asset coverage requirement set forth in the 1940 Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Trust would not be able to liquidate portfolio securities in a manner that is orderly and consistent with the Trust's investment objectives and policies in order to purchase Shares tendered pursuant to the Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) there is, in the Board's judgment, any (i) legal action or proceeding instituted or threatened challenging the Offer or otherwise materially adversely affecting the Trust, (ii) declaration of a banking moratorium by Federal or state authorities or any suspension of payment by banks in the United States or New York State, which is material to the Trust, (iii) limitation imposed by Federal or state authorities on the extension of credit by lending institutions, (iv) commencement of war, armed hostilities, acts of terrorism or other international or national calamity directly or indirectly involving the United States that in the sole determination of the Board is material to the Trust, or (v) other events or conditions that would have a material adverse effect on the Trust or its shareholders if Shares tendered pursuant to the Offer were purchased; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the Board determines that effecting the Offer would be inconsistent with applicable legal requirements or would constitute a breach of the Board's fiduciary duties owed to the Trust or its shareholders.

The foregoing conditions are for the Trust's sole benefit and may be asserted by the Trust regardless of the circumstances giving rise to any such condition (including any action or inaction of the Trust), and any such condition may be waived by the Trust, in whole or in part, at any time and from time to time in its reasonable judgment. The Trust's failure at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right; the waiver of any such right with respect to particular facts and circumstances shall not be deemed a waiver with respect to any other facts or circumstances; and each such right shall be deemed an ongoing right which may be asserted at any time and from time to time. Any determination by the Trust concerning the events described in this Section 4 shall be final and binding.

------

##### [**Table of Contents**](#toc)
The Trust reserves the right, at any time during the pendency of the Offer, to terminate, extend or amend the Offer in any respect. If the Trust determines to terminate or amend the Offer or to postpone the acceptance for payment of or payment for Shares tendered, it will, to the extent necessary, extend the period of time during which the Offer is open as provided in Section 15, "Amendments; Extensions of Purchase Period; Termination." In the event any of the foregoing conditions are modified or waived in whole or in part at any time, the Trust will promptly make a public announcement of such waiver and may, depending on the materiality of the modification or waiver, extend the Offer period as provided in Section 15, "Amendments; Extensions of Purchase Period; Termination."

**5.** **Procedures for Tendering Shares for Purchase.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*A. Proper Tender of Shares.* 

If you would like to participate in the Offer and have a direct shareholder account held with the Trust (*i.e.*, you receive account statements directly from BlackRock), please complete, sign and date the accompanying Tender Request Form. In order to process your request, it must be received in good order by the Transfer Agent, at P.O. Box 9819, Providence, RI 02940, prior to the Expiration Date. Delivery to an address other than that shown above does not constitute valid delivery.

If you would like to participate in the Offer and your shares are held through a Financial Intermediary, please ask your financial adviser, broker/dealer or other financial intermediary to submit a repurchase request for you. You may be charged a transaction fee for this service by your financial adviser, broker/dealer or other financial intermediary. Please consider broker/dealer processing time that may be needed prior to the Expiration Date.

**Tender Request Forms should not be sent or delivered to the Trust.** 

Section 14(e) of the Exchange Act and Rule 14e-4 promulgated thereunder make it unlawful for any person, acting alone or in concert with others, directly or indirectly, to request a purchase of Shares pursuant to the Offer unless at the time of the request, and at the time the Shares are accepted for payment, the person requesting the purchase has a net long position equal to or greater than the amount requested for purchase in either: (a) Shares, and will deliver or cause to be delivered such Shares for the purpose of purchase to the Trust within the period specified in the Offer, or (b) an equivalent security and, upon the acceptance of his or her request to purchase, will acquire Shares by conversion, exchange, or exercise of such equivalent security to the extent required by the terms of the Offer, and will deliver or cause to be delivered the Shares so acquired for the purpose of requesting the purchase to the Trust prior to or on the Expiration Date. Section 14(e) and Rule 14e-4 provide a similar restriction applicable to the request to purchase or guarantee of a request to tender on behalf of another person.

The acceptance of Shares by the Trust for purchase will constitute a binding agreement between the participating shareholder and the Trust upon the terms and subject to the conditions of the Offer, including the participating shareholder's representation that the shareholder has a net long position in the Shares being tendered for purchase within the meaning of Rule 14e-4 and that the request to tender such Shares complies with Rule 14e-4.

By submitting the Tender Request Form, a tendering shareholder shall, subject to and effective upon acceptance for payment of the Shares tendered, be deemed in consideration of such acceptance to sell, assign and transfer to, or upon the order of, the Trust all right, title and interest in and to all the Shares that are being tendered (and any and all dividends, distributions, other Shares or other securities or rights declared or issuable in respect of such Shares after the Expiration Date) and irrevocably constitute and appoint the Transfer Agent the true and lawful agent and attorney-in-fact of the tendering shareholder with respect to such Shares (and any such dividends, distributions, other Shares or securities or rights), with full power of substitution (such power of attorney being deemed to be an irrevocable power coupled with an interest) to (a) present such Shares (and any

------

##### [**Table of Contents**](#toc)
such other dividends, distributions, other Shares or securities or rights) for transfer on the books of the Trust, and (b) receive all benefits and otherwise exercise all rights of beneficial ownership of such Shares (and any such other dividends, distributions, other Shares or securities or rights), all in accordance with the terms of the Offer. Upon such acceptance for payment, all prior powers of attorney given by the tendering shareholder with respect to such Shares (and any such dividends, distributions, other shares or securities or rights) will, without further action, be revoked and no subsequent powers of attorney may be given by the tendering shareholder with respect to the tendered Shares (and, if given, will be null and void).

By submitting a Tender Request Form, and in accordance with the terms and conditions of the Offer, a tendering shareholder shall be deemed to represent and warrant that: (a) the tendering shareholder has full power and authority to tender, sell, assign and transfer the tendered Shares (and any and all dividends, distributions, other Shares or other securities or rights declared or issuable in respect of such Shares after the Expiration Date); (b) when and to the extent the Trust accepts the Shares for purchase, the Trust will acquire good, marketable and unencumbered title thereto, free and clear of all liens, restrictions, charges, proxies, encumbrances or other obligations relating to their sale or transfer, and not subject to any adverse claim; (c) on request, the tendering shareholder will execute and deliver any additional documents deemed by the Transfer Agent or the Trust to be necessary or desirable to complete the sale, assignment and transfer of the tendered Shares (and any and all dividends, distributions, other Shares or securities or rights declared or issuable in respect of such Shares after the Expiration Date); and (d) the tendering shareholder has read and agreed to all of the terms of the Offer, including this Offer to Purchase and the Tender Request Form.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*B. Signature Guarantees and Method of Delivery.* If any of the Shares tendered for purchase thereby are owned of record by two or more joint owners, all such owners must sign the Tender Request Form.

If any of the Shares tendered for purchase are registered in different names, it is necessary to complete, sign and submit as many separate Tender Request Form as there are different registrations.

If the Tender Request Form is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Trust of their authority so to act must be submitted together with the Tender Request Form.

**THE METHOD OF DELIVERY OF ANY DOCUMENTS IS AT THE ELECTION AND RISK OF THE PARTY TENDERING SHARES. IF DOCUMENTS ARE SENT BY MAIL, IT IS RECOMMENDED THAT THEY BE SENT BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*C. Determinations of Validity.* All questions as to the validity, form, eligibility (including time of receipt) and acceptance of tenders will be determined by the Trust, in its sole discretion, which determination shall be final and binding. The Trust reserves the absolute right to reject any or all tenders determined not to be in appropriate form or to refuse to accept for payment or purchase, or pay for, any Shares if, in the opinion of the Trust's counsel, accepting, purchasing or paying for such Shares would be unlawful. The Trust also reserves the absolute right to the extent permitted by law to waive any of the conditions of the Offer or any defect in any tender, whether generally or with respect to any particular Share(s) or shareholder(s). The Trust's interpretations of the terms and conditions of the Offer (including the Tender Request Form and the instructions thereto) shall be final and binding.

**None of the Trust, the Board of Trustees, the Investment Advisor, the Transfer Agent nor any other person is or will be obligated to give any notice of any defect or irregularity in any tender, and none of the foregoing persons will incur any liability for failure to give any such notice.** 

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*D. U.S. Federal Income Tax Withholding.* Under the U.S. federal income tax backup withholding rules, the Transfer Agent would generally be required to withhold 24% of the gross payments made pursuant to the Offer to any U.S. Shareholder (as defined below) unless such U.S. Shareholder has completed and submitted to the Transfer Agent an IRS Form W-9. In order to avoid the possibility of backup withholding, all participating U.S. Shareholders are required to provide the Transfer Agent with a properly completed and signed IRS Form W-9. A "U.S. Shareholder" is a shareholder that is a "U.S. person" within the meaning of the Internal Revenue Code of 1986, as amended (the "Code"). In general, a U.S. Shareholder is a shareholder that is (a) an individual who is a citizen or resident of the United States; (b) a corporation or partnership, or other entity taxed as a corporation or partnership, created or organized in the United States or under the law of the United States or of any State thereof; (c) an estate the income of which is subject to U.S. federal income taxation regardless of the source of such income; or (d) a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust.

In order to avoid backup withholding, participating Non-U.S. Shareholders (as defined below) must provide the Transfer Agent with a completed IRS Form W-8BEN or W-8BEN-E, or another type of Form W-8 appropriate to the particular Non-U.S. Shareholder. For purposes of this Offer to Purchase, a "Non-U.S. Shareholder" is generally any shareholder that is not a "U.S. person" within the meaning of the Code. Copies of Form W-8BEN or W-8BEN-E are provided with the Tender Request Form for Non-U.S. Shareholders. Other types of Form W-8 can be found on the IRS website at www.irs.gov/formspubs/index.html.

Tendering Non-U.S. Shareholders may be subject to U.S. federal withholding tax, even if they submit an appropriate IRS Form W-8 in order to claim an exemption from backup withholding. For an additional discussion of U.S. federal income tax withholding as well as a discussion of certain other U.S. federal income tax consequences to tendering shareholders, see Section 13, "Certain U.S. Federal Income Tax Consequences."

**6.** **Withdrawal Rights.** 

At any time prior to the Expiration Date any shareholder may withdraw all, but not less than all, of the Shares that the shareholder has tendered. In addition, Shareholders will also have the right to withdraw the tender of Shares at any time after 4:00 p.m. on March 8, 2023, to the extent the Shares have not yet been accepted for payment as of that date.

If your Shares are held at your Financial Intermediary, you may withdraw your tendered Shares prior to the Expiration Date by submitting notice to your Financial Intermediary. In the event you decide to modify or withdraw your tender, you should provide your Financial Intermediary with sufficient notice prior to the Expiration Date. If you have a direct shareholder account held with the Trust, tender requests submitted pursuant to the Offer may be modified or withdrawn at any time prior to the Expiration Date by submitting notice to the Transfer Agent at the address indicated in the Tender Request Form, and the Transfer Agent must receive the notice before the Expiration Date. You may resubmit withdrawn Shares by following the purchase procedures before the Offer expires, including during any extension period.

All questions as to the validity, form and eligibility (including time of receipt) of notices of withdrawal will be determined by the Trust in its sole discretion, which determination shall be final and binding. Shares properly withdrawn will not thereafter be deemed to be tendered for purposes of the Offer. Withdrawn Shares, however, may be re-tendered for purchase by following the procedures described in Section 5 prior to the Expiration Date. Except as otherwise provided in this Section 6, tenders of Shares made pursuant to the Offer will be irrevocable.

**None of the Trust, the Board of Trustees, the Investment Advisor, the Transfer Agent nor any other person is or will be obligated to give any notice of any defect or irregularity in any notice of withdrawal, nor shall any of them incur any liability for failure to give any such notice.** 

------

##### [**Table of Contents**](#toc)
**7.** **Payment for Shares.** 

For purposes of the Offer, the Trust will be deemed to have accepted for payment and purchased Shares that are tendered for purchase (and not timely withdrawn in accordance with Section 6) when, as and if the Trust gives oral or written notice to the Transfer Agent of its acceptance of such Shares for purchase pursuant to the Offer. Under the Exchange Act, the Trust is obligated to pay for or return Shares tendered for purchase promptly after the termination, expiration or withdrawal of the Offer.

Payment for all Shares purchased pursuant to the Offer will be made promptly. The Trust expressly reserves the right, in its sole discretion, to delay payment for Shares in order to comply in whole or in part with any applicable law. Under no circumstances will the Trust pay interest on the purchase price of the Shares to be paid by the Trust, regardless of any delay in making such payment.

If any tendered Shares are not accepted for payment or are not paid because of an invalid tender or if a shareholder withdraws tendered Shares, (i) the Shares will be issued in book-entry form and will be electronically held in your account for such unpurchased Shares, as soon as practicable following the expiration, termination or withdrawal of the Offer, (ii) Shares delivered pursuant to the book-entry delivery procedures will be credited to the account from which they were delivered, and (iii) uncertificated Shares held by the Trust's transfer agent pursuant to the Trust's dividend reinvestment plan will be returned to the automatic dividend reinvestment plan account maintained by the transfer agent.

The Trust will pay all transfer taxes, if any, payable on the transfer to it of Shares purchased pursuant to the Offer. If, however, payment of the purchase price is to be made to, or if unpurchased Shares were registered in the name of, any person other than the tendering holder, the amount of any transfer taxes (whether imposed on the registered holder or such other person) payable on account of such transfer will be deducted from the purchase price unless satisfactory evidence of the payment of such taxes, or exemption therefrom, is submitted. In addition, if certain events occur, the Trust may not be obligated to purchase Shares pursuant to the Offer. See Section 4, "Certain Conditions of the Offer."

**8.** **Source and Amount of Consideration.** 

The actual cost of the Offer to the Trust cannot be determined at this time because the number of Shares to be purchased will depend on the number of Shares tendered for purchase, and the price will be based on the NAV per Share on the Pricing Date. If shareholders tendered all Shares offered for purchase pursuant to the Offer, and the Trust purchased such Shares at a price per share of $69.84, the NAV as of January 3, 2023, payments by the Trust to the participating shareholders would be approximately $4.36 million. See Section 9, "Effects of the Offer; Consequences of Participation."

The monies to be used by the Trust to purchase Shares pursuant to the Offer will be first obtained from any cash on hand and then from the proceeds of sales of securities in the Trust's investment portfolio. The Board of Trustees believes that the Trust has sufficient liquidity to purchase the Shares that may be tendered pursuant to the Offer. However, if, in the judgment of the Board of Trustees, there is not sufficient liquidity of the assets of the Trust to pay for tendered Shares, the Trust may terminate the Offer.

Other than potentially through the use of reverse repurchase agreements, no funds are expected to be borrowed, directly or indirectly, for the purpose of the Offer. There are no alternative financing arrangements or alternative financing plans. There are no material conditions to the availability of the Consideration for the purposes of this Offer, except as set forth herein. See Section 4, "Certain Conditions of the Offer."

**9.** **Effects of the Offer; Consequences of Participation.** 

The Offer may have certain adverse consequences for tendering and non-tendering shareholders.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*A. Effects on NAV and Consideration Received by Tendering Shareholders.* To pay the aggregate purchase price of Shares accepted for payment pursuant to the Offer, the Trust anticipates that funds will be first derived from any cash on hand and then from the proceeds from the sale of portfolio securities held by the Trust. If the Trust is required to sell a substantial amount of portfolio securities to raise cash to finance the Offer, such dispositions of portfolio securities could cause market prices of the Trust's portfolio securities, and hence the Trust's NAV, to decline. If such a decline occurs, the Trust cannot predict what its magnitude might be or whether such a decline would be temporary or continue to or beyond the Expiration Date. Because the price per Share to be paid in the Offer will be dependent upon the NAV as determined as of the close of ordinary trading on the NYSE on the Pricing Date, if such a decline continued to the Pricing Date, the consideration received by tendering shareholders would be less than it otherwise might have been. In addition, a sale of portfolio securities will result in increased brokerage and related transaction expenses, and the Trust may receive proceeds from the sale of portfolio securities that are less than the valuations of such securities by the Trust. Accordingly, because of the Offer, the Trust's NAV may decline more than it otherwise might, thereby reducing the amount of proceeds received by tendering shareholders, and also reducing the NAV for non-tendering shareholders.

The Trust will sell portfolio securities to raise cash for the purchase of Shares. Thus, it is likely that during the pendency of the Offer, and possibly for a short time thereafter, the Trust will hold a greater than normal percentage of its net assets in cash and cash equivalents. This larger cash position may interfere with the Trust's ability to meet its investment objective. The Trust is required by law to pay for tendered Shares it accepts for payment promptly after the Expiration Date of this Offer. If on or prior to the Expiration Date the Trust does not have, or believes it is unlikely to have, sufficient cash to pay for all Shares tendered, it may extend the Offer to allow additional time to sell portfolio securities and raise sufficient cash.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*B. Recognition of Capital Gains*. As noted, the Trust will likely be required to sell portfolio securities pursuant to the Offer. If the Trust's tax basis for the securities sold is less than the sale proceeds, the Trust will recognize capital gains. The Trust would expect to distribute any such gains to shareholders of record (reduced by net capital losses realized during the fiscal year, if any, and available capital loss carry-forwards) during, or following the end of, the Trust's fiscal year. This recognition and distribution of gains, if any, would have two negative consequences: first, while shareholders at the time of a declaration of distributions will receive such distributions, such shareholders would be required to pay taxes on a greater amount of capital gain distributions than otherwise would be the case; and second, to raise cash to make the distributions, the Trust might need to sell additional portfolio securities, thereby possibly being forced to realize and recognize additional capital gains. It is impossible to predict what the amount of unrealized gains or losses would be in the Trust's portfolio at the time that the Trust is required to liquidate portfolio securities (and hence the amount of capital gains or losses that would be realized and recognized). As of December 31, 2021, the Trust had unrealized capital depreciation of approximately $2.5 million. As of December 31, 2021, the Trust had non-expiring capital loss carryforwards of approximately $11.6 million.

In addition, some distributed gains may be realized on securities held for one year or less, which would generate income taxable to the shareholders at ordinary income rates. This could adversely affect the Trust's after-tax performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*C. Tax Consequences of Purchases to Shareholders*. The Trust's purchase of tendered Shares pursuant to the Offer will have tax consequences for tendering shareholders. See Section 13, "Certain U.S. Federal Income Tax Consequences."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*D. Effect on Remaining Shareholders, Higher Expense Ratio and Less Investment Flexibility*. The purchase of Shares by the Trust pursuant to the Offer will have the effect of increasing the proportionate interest in the Trust of non-tendering shareholders. All shareholders remaining after the Offer will be subject to any increased risks associated with the reduction in the Trust's aggregate assets resulting from payment for the tendered Shares, such as greater volatility due to decreased diversification and proportionately higher expenses due to a decreased asset base. The reduced net assets of the Trust as a result of the Offer may result in less investment flexibility for the Trust and may have an adverse effect on the Trust's investment performance.

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*E. Effect on Leverage*. The Trust currently utilizes leverage through reverse repurchase agreements. As of December 31, 2022, this leverage represented approximately 14.53% of the Trust's Managed Assets (approximately 17.01% of the Trust's net assets). The Trust's net assets attributable to Shares are the Trust's Managed Assets minus the value of the Trust's assets attributable to money borrowed for investment purposes. The Trust intends to maintain approximately the same level of economic leverage, as a percentage of Managed Assets, following the Offer. Based on the number of Shares purchased in the Offer, the Trust may reduce its use of reverse repurchase agreements in order to maintain the Trust's overall economic leverage targets. This de-levering may result in decreased returns to the Trust and increased expenses for remaining shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*F. Possible Proration*. If greater than the Offer Amount of the Trust's Shares are tendered pursuant to the Offer, the Trust would, upon the terms and subject to the conditions of the Offer, purchase Shares tendered on a pro rata basis. Accordingly, shareholders cannot be assured that all of their tendered Shares will be purchased.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*G. Potential Impact of the Offer on the Trust's Status as a "Publicly Offered Regulated Investment Company."* For the taxable year ended December 31, 2022 and all prior taxable years, the Trust has been treated as a "publicly offered regulated investment company." To be treated as a "publicly offered regulated investment company," the Trust's shares must, among other things, be held by or for at least 500 persons at all times during the taxable year. As of December 31, 2022, the Trust's shares were held by 508 persons. This number could decrease below 500 persons in a future taxable year as a result of shareholders' shares being repurchased in one or more quarterly tender offers, including the Offer. The failure of the Trust to be treated as a "publicly offered regulated investment company" in a given taxable year could have potential adverse tax consequences for U.S. shareholders that are individuals, trusts, estates, and certain other pass-through entities. In such situation, each affected shareholder will be treated as receiving a distribution equal to that shareholder's allocable share of management fees and certain other expenses paid by the Trust ("Trust Fees and Expenses"), but will not be able to take an offsetting deduction. Trust Fees and Expenses will be treated as miscellaneous itemized deductions, which are currently not deductible by such U.S. shareholders. Shareholders should consult with their tax advisors regarding the potential individual tax consequences should the Trust fail to be treated as a "publicly offered regulated investment company" in a given taxable year.

**10.** **Interests of Trustees and Officers; Transactions and Arrangements Concerning the Shares** 

Information, as of particular dates, concerning the Trust's trustees and executive officers, their remuneration, any material interest of such persons in transactions with the Trust and other matters, is required to be disclosed in proxy statements distributed to the Trust's shareholders and filed with the Commission. The business address and business telephone number of each trustee and executive officer of the Trust are in care of BlackRock, Inc., 55 East 52nd Street, New York, NY 10055.

As of January 3, 2023, Glenn Hubbard, a trustee of the Trust, owned 1,333 Shares of the Trust and W. Carl Kester, a trustee of the Trust, owned 133 Shares of the Trust. To the best of the Trust's knowledge, no other trustee or executive officer of the Trust beneficially owned Shares of the Trust as of January 3, 2023. Except as noted below, to the best of the Trust's knowledge, no person controlling the Trust or the Investment Advisor nor any associate or majority-owned subsidiary of such person beneficially owned Shares of the Trust as of January 3, 2023.

None of the Trust, the Investment Advisor or, to the best of the Trust's knowledge, any of the Trust's trustees or executive officers or any person controlling the Trust or the Investment Advisor, has effected any transaction in Shares, except for dividend reinvestment, during the 60 days prior to the date of this Offer to Purchase.

Except as set forth in this Offer to Purchase, none of the Trust, the Investment Advisor or, to the best of the Trust's knowledge, any of the Trust's trustees or executive officers or any person controlling the Trust or the Investment Advisor, is a party to any agreement, arrangement, or understanding, whether or not legally

------

##### [**Table of Contents**](#toc)
enforceable, with any other person with respect to any securities of the Trust, including, but not limited to, any agreement, arrangement, understanding or relationship concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guaranties of loans, guaranties against loss or the giving or withholding of proxies, consents or authorizations. Except as set forth in this Offer to Purchase, there is no present or proposed material agreement, arrangement, understanding or relationship with respect to the Offer between the Trust and any of its executive officers, trustees, controlling persons or subsidiaries.

The Trust has been advised that neither its Board of Trustees nor its officers intend to tender any Shares pursuant to the Offer. Therefore, the Trust does not intend to purchase Shares from any officer or Trustee pursuant to the Offer. As of January 3, 2023, BlackRock Financial Management, Inc., an affiliate of the Investment Advisor, owned 1,333 Shares of the Trust. The Trust has been advised that BlackRock Financial Management, Inc. does not intend to tender any Shares pursuant to the Offer.

To the knowledge of the Trust, the following entities owned of record or beneficially 5% or more of the Fund's shares as of January 3, 2023:

---

| | | |
|:---|:---|:---|
| **Name** | **Address** | **%** |
| UBS Financial Services Inc.<br> FBO ICT Holdings LLC | 316 California Avenue, Suite 448<br> Reno, NV 89509 | 5.34% |

---

BlackRock Advisors, LLC acts as the investment adviser for the Trust. Pursuant to an investment advisory agreement between the Investment Advisor and the Trust (the "Investment Advisory Agreement"), the Trust pays the Investment Advisor a monthly fee at an annual rate of 1.25% of the Trust's average daily Managed Assets. To mitigate any potential economic impact should the Trust fail to be treated as a "publicly offered regulated investment company", effective January 1, 2022, the Investment Advisor has voluntarily agreed to waive its annual management fee rate by 0.25%, such that the Trust will be subject to a net management fee at an annual rate of 1.00% of the average daily value of the Trust's Managed Assets. The Investment Advisor may terminate this voluntary waiver at any time without notice. The fees waived under the voluntary management fee waiver are not subject to recoupment by the Investment Advisor. Because the investment advisory fee is calculated on the basis of Managed Assets, which includes assets purchased with leverage, the fee paid to the Investment Advisor during periods in which the Trust is using leverage will be higher than if the Trust did not use leverage.

The Investment Advisor has entered into sub-advisory agreements (each, a "Sub-Advisory Agreement") with BlackRock International Limited ("BIL") and BlackRock (Singapore) Limited ("BRS"), each an affiliate of the Investment Advisor (the "Sub-Advisors"). The Investment Advisor pays BIL and BRS for services they provide for that portion of the Trust for which BIL and BRS acts as sub-adviser a monthly fee that is equal to a percentage of the investment advisory fees paid by the Trust to the Investment Advisor.

A discussion regarding the basis for the approval of the Investment Advisory Agreement and Sub-Advisory Agreements by the Board is available in the Trust's Semi-Annual Report to shareholders for the period ended June 30, 2022.

The Trust also is a party to certain other service agreements. The Trust is a party to a Transfer Agency and Shareholder Services Agreement with the Transfer Agent. BNY Mellon receives annual compensation from the Trust and is entitled to reimbursement of out-of-pocket expenses for the services it provides as transfer agent, registrar, dividend disbursing agent and shareholder servicing agent for the Trust.

State Street Bank and Trust Company ("State Street") serves as custodian for the Trust's portfolio securities pursuant to the Custodian Agreement ("Custodian Agreement") entered into with the Trust. Under the Custodian Agreement, the Trust is obligated to pay State Street reasonable compensation for its services and expenses as agreed upon from time to time between the Trust and State Street.

The amounts paid by the Trust under these service agreements are disclosed in the Trust's financial statements, which can be found in the Trust's annual and semi-annual reports.

------

##### [**Table of Contents**](#toc)
**11.** **Certain Information about the Trust.** 

The Trust was organized as a Delaware statutory trust on May 11, 2018 pursuant to its Certificate of Trust and Agreement and Declaration of Trust, is governed by the laws of the State of Delaware, and commenced operations on April 16, 2019. The Trust is registered under the 1940 Act as a diversified, closed-end management investment company. The Trust's principal office is located at 100 Bellevue Parkway, Wilmington, Delaware 19809, and its telephone number is (800) 882-0052. As a closed-end investment company, the Trust differs from an open-end investment company (i.e., a mutual fund) in that it does not redeem its Shares at the election of a shareholder. Shares are not traded on any established trading market and are subject to restrictions on transferability pursuant to the Agreement and Declaration of Trust.

The Trust's investment objective is to seek to provide high income and total return. The Trust may invest in a broad range of debt and equity instruments, sectors and strategies to achieve its investment objective. Under normal conditions, the Trust will invest at least 80% of its total assets in fixed income securities and other financial instruments that pay periodic income. The Trust may invest any amount of its assets in securities of any credit quality, including securities that are rated at the time of investment below investment grade — i.e., ''Ba'' or ''BB'' or below by Moody's Investor's Service, Inc., S&P Global Ratings or Fitch Ratings, Inc., or securities that are judged to be of comparable quality by the Investment Advisor and the Sub-Advisors. The Trust's investment objective may be changed without prior shareholder approval. There can be no assurance that the investment objective of the Trust will be achieved.

BlackRock Advisors, LLC acts as the investment adviser for the Trust. The Investment Advisor is responsible for the management of the Trust's portfolio and provides the necessary personnel, facilities, equipment and certain other services necessary to the operation of the Trust. The Investment Advisor, located at 100 Bellevue Parkway, Wilmington, Delaware 19809, is a wholly-owned subsidiary of BlackRock, Inc. The Investment Advisor has entered into Sub-Advisory Agreements with the Sub-Advisors, each of which is an affiliate of the Investment Advisor.

**12.** **Additional Information.** 

The Trust has filed with the Commission a Schedule TO, which provides additional information relating to the Offer. You may inspect and obtain a copy of Schedule TO by visiting the EDGAR database on the Commission's website (http://www.sec.gov). Copies of the Schedule TO can be obtained, for a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov.

**13.** **Certain U.S. Federal Income Tax Consequences.** 

The following discussion is a general summary of certain U.S. federal income tax consequences of a participating shareholder's sale of Shares pursuant to the Offer. This discussion is based on current U.S. federal income tax law, including the Code, existing and proposed Treasury regulations, administrative pronouncements and judicial decisions, all as currently in effect and all of which are subject to change, possibly with retroactive effect. This discussion does not apply to a shareholder that is a member of a class of holders subject to special rules (such as a dealer in securities, a trader in securities that elects to use a mark-to-market method of accounting for its securities holdings, a bank, a life insurance company, a tax-exempt organization, a person that owns Shares as part of a hedging, integrated, conversion or constructive sale transaction or as a position in a straddle, a partnership or other pass-through entity for U.S. federal income tax purposes, an accrual basis taxpayer subject to special tax accounting rules under Section 451(b) of the Code or a U.S. Shareholder (as such term is defined in Section 5, "Procedures for Tendering Shares for Purchase—U.S. Federal Income Tax Withholding" above) whose functional currency for tax purposes is not the U.S. dollar). This summary assumes that the Trust is and will remain a RIC for U.S. federal income tax purposes for the taxable year that includes the purchase of Shares pursuant to the Offer. No ruling has been or will be sought from the Internal Revenue Service ("IRS") regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax aspects set forth below. Shareholders must consult

------

##### [**Table of Contents**](#toc)
their own tax advisers with respect to the tax consequences of a sale of Shares pursuant to the Offer, including potential tax consequences in jurisdictions where the shareholder is a citizen, resident or domiciliary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*A. Consequences to U.S. Shareholders of Participating in the Offer.*

<u>In General</u>. A shareholder's tender of all or a part of its Shares for cash pursuant to the Offer will be a taxable transaction for U.S. federal income tax purposes. The tax consequences of the sale will be determined in part under the stock redemption rules of Section 302 of the Code. The amount and characterization of income recognized by a shareholder in connection with a sale pursuant to the Offer will depend on whether the sale is treated as an "exchange" or a "dividend" for tax purposes.

<u>Treatment as an Exchange</u>. If the redemption qualifies under any of the provisions of Section 302(b) of the Code, as more fully described below, the cash received pursuant to the Offer will be treated as received in exchange for the Shares sold. The treatment accorded to such an exchange results in a shareholder's recognizing gain or loss equal to the difference between (a) the cash received by the shareholder pursuant to the Offer and (b) the shareholder's adjusted tax basis in the Shares surrendered. Assuming the Shares are held as capital assets, such recognized gain or loss will be capital gain or loss. If the Shares were held longer than one year, such capital gain or loss will be long-term. If the Shares were held for one year or less, such capital gain or loss will be short-term. However, any loss upon an exchange of Shares held for six months or less generally will be treated as a long-term capital loss to the extent of distributions received or deemed received from the Trust that were treated as long-term capital gain. In addition, under certain "wash sales" rules, recognition of a loss on Shares sold pursuant to the Offer will ordinarily be disallowed to the extent a shareholder acquires Shares within 30 days before or after the date Shares are purchased pursuant to the Offer and, in that event, the basis and holding period of the Shares acquired will be adjusted to reflect the disallowed loss. The deductibility of capital losses is subject to a number of limitations under the Code.

<u>Treatment as a Dividend</u>. If none of the provisions under Section 302(b) of the Code outlined below are satisfied, a shareholder will be treated as having received a distribution on its Shares. Any such distribution will be treated as taxable dividend income in an amount equal to the entire amount of cash received by the shareholder for its Shares pursuant to the Offer to the extent the Trust has current or accumulated earnings and profits. Any amounts treated as distributions to shareholders in excess of the Trust's current and accumulated earnings and profits will be treated as a return of capital to such shareholders to the extent of their basis in their Shares (reducing that basis accordingly) and then as capital gain (which will be long-term or short-term depending on such shareholder's applicable holding period for the Shares tendered).

Accordingly, the difference between "dividend" and "sale or exchange" treatment is important with respect to the amount (there is no basis offset for dividends) and character of income that tendering shareholders are deemed to receive. While the marginal tax rate for dividends and capital gains remains the same for corporate shareholders, under the Code the top income tax rate on ordinary dividend income and short-term capital gains of individuals generally exceeds the maximum tax rate on long-term capital gains.

Each shareholder's tax adviser should determine whether that shareholder qualifies under one of the provisions of Section 302(b) of the Code. In the event that the transaction is treated as a dividend distribution to a shareholder for federal income tax purposes, such shareholder's remaining tax basis in the Shares actually redeemed will be added to the tax basis of such shareholder's remaining Shares in the Trust. In the event that a shareholder actually owns no Shares in the Trust after the redemption, but the transaction is nevertheless treated as a dividend distribution because such shareholder constructively owns Shares in the Trust (see below), such shareholder's tax basis may, under certain circumstances, be added to Shares in the Trust owned by related persons that were considered constructively owned by such shareholder, or may be lost entirely. With respect to a purchase of Shares that is treated as a distribution but that is not otherwise taxable as a dividend because it exceeds the Trust's earnings and profits, the method by which a U.S. holder must reduce its basis is uncertain in situations where the holder owns different blocks of shares that were acquired at different prices and thus have

------

##### [**Table of Contents**](#toc)
different bases. Each shareholder should consult its tax adviser with respect to the particular U.S. federal income tax consequences to such shareholder of participating in the Offer.

<u>Constructive Ownership of Shares</u>. In determining whether the provisions under Section 302(b) of the Code, as described below, are satisfied, a shareholder must take into account not only Shares actually owned by such shareholder, but also Shares that are constructively owned within the meaning of Section 318 of the Code. Under Section 318 of the Code, a shareholder may constructively own Shares actually owned, and in some cases constructively owned, by certain related individuals and certain entities in which the shareholder or a related individual or entity has an interest. The rules of constructive ownership are complex and must be applied to a particular shareholder's situation by a tax adviser.

<u>The Provisions of Section</u> <u>302(b) of the Code</u>. Under Section 302(b) of the Code, a redemption will be taxed as an exchange, and not as a dividend, if it (a) results in a "complete redemption" of all the Shares owned by a shareholder, (b) is "substantially disproportionate" with respect to a shareholder, or (c) is "not essentially equivalent to a dividend" with respect to a shareholder. Each shareholder should be aware that, under certain circumstances, sales, purchases, or transfers of Shares in the market or to or from other parties contemporaneous with sales pursuant to the Offer may be taken into account in determining whether the tests under clause (a), (b), or (c) above are satisfied. Further, the Trust believes that in the event the Offer is oversubscribed, resulting in a proration, it is likely that less than all the Shares tendered by a shareholder will be purchased by the Trust. Proration may affect whether a sale by a shareholder will satisfy the provisions (a), (b), or (c) above.

A brief description of the three major applicable provisions of Section 302(b) of the Code is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. *A Complete Redemption of Interest.* The receipt of cash by a shareholder will result in a "complete
redemption" of all the Shares owned by the shareholder within the meaning of Section 302(b)(3) of the Code if either (i) all the Shares actually and constructively owned by the shareholder are sold pursuant to the Offer or
(ii) all the Shares actually owned by the shareholder are sold pursuant to the Offer, the only Shares the shareholder constructively owns are actually owned by such shareholder's family members, and the shareholder is eligible to waive and
effectively waives, under procedures described in Section 302(c) of the Code, such constructive ownership. Shareholders wishing to satisfy the "complete termination" test through waiver of the constructive ownership rules should
consult their tax advisers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. *A Substantially Disproportionate Redemption.* The receipt of cash by a shareholder will be
"substantially disproportionate" with respect to such shareholder within the meaning of Section 302(b)(2) of the Code if (i) the percentage of the total outstanding Shares actually and constructively owned by the shareholder
immediately following the sale of Shares pursuant to the Offer is less than 80 percent of the percentage of the total outstanding Shares actually and constructively owned by such shareholder immediately before such sale, and
(ii) immediately following the exchange, the shareholder actually and constructively owns less than 50% of the total combined voting power of all classes of voting shares of the Trust.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. *Not Essentially Equivalent to a Dividend.* Even if a sale by a shareholder fails to meet the
"complete redemption" or "substantially disproportionate" tests, a shareholder may nevertheless meet the "not essentially equivalent to a dividend" test. Whether a specific redemption is "not essentially equivalent
to a dividend" depends on the individual shareholder's facts and circumstances. In any event, the redemption must result in a "meaningful reduction" of the shareholder's proportionate interest in the Trust. The IRS has
indicated in a published ruling that, in the case of a minority stockholder in a publicly held corporation whose relative stock investment in the corporation was minimal and who exercised no control over corporate affairs, a small reduction in the
percentage ownership interest of such stockholder in such corporation was sufficient to constitute a "meaningful reduction." Shareholders seeking to rely on this test should consult their own tax advisers as to the application of this
particular standard to their own situations.

------

##### [**Table of Contents**](#toc)
<u>Backup Withholding</u>. The Transfer Agent may be required to withhold 24% of the gross proceeds paid to a shareholder or other payee pursuant to the Offer unless either: (a) the shareholder has completed and submitted to the Transfer Agent an IRS Form W-9 (including the Substitute IRS Form W-9, if one is included with the Tender Request Form) providing the shareholder's taxpayer identification number/social security number and certifying under penalties of perjury: (i) that such number is correct, (ii) either that (A) the shareholder is exempt from backup withholding, (B) the shareholder has not been notified by the IRS that the shareholder is subject to backup withholding as a result of an under-reporting of interest or dividends, or (C) the IRS has notified the shareholder that the shareholder is no longer subject to backup withholding, (iii) the shareholder is a U.S. citizen or other U.S. person (as defined in IRS Form W-9), and (iv) the FATCA code(s) entered on the form (if any) indicating that the shareholder is exempt from FATCA reporting is correct; or (b) an exception applies under applicable law and Treasury regulations.

<u>Medicare Tax</u>. Certain U.S. Shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a portion of their "net investment income," which generally includes capital gains or dividends recognized upon a sale of Shares pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*B. Consequences to Non-U.S. Shareholders of the Trust's Purchase of Shares Pursuant to the Offer*

<u>U.S. Withholding at the Source</u>. Since the Trust cannot determine whether a payment made pursuant to the Offer should be characterized for any particular shareholder as an "exchange" or a "dividend" for tax purposes at the time of the payment, we or the applicable withholding agent may treat any payments to a tendering shareholder that is a Non-U.S. Shareholder and that does not hold its Shares in connection with a trade or business conducted in the United States (and, if required by an applicable income tax treaty, a U.S. permanent establishment) as a dividend for U.S. federal income tax purposes that is subject to U.S. withholding tax at the rate of 30% (or lower rate provided by an applicable treaty). This U.S. withholding tax will apply even if the Non-U.S. Shareholder has provided the required certification to avoid backup withholding. In order to obtain a reduced rate of withholding under an applicable tax treaty, a Non-U.S. Shareholder must deliver to the Transfer Agent before the payment a properly completed and executed IRS Form W-8BEN or W-8BEN-E. In order to obtain an exemption from withholding on the grounds that the Non-U.S. Shareholder holds its Shares in connection with a trade or business conducted in the United States, the Non-U.S. Shareholder must deliver to the Transfer Agent a properly completed and executed IRS Form W-8ECI. Such forms (and additional IRS forms) may be obtained from the **Transfer Agent** or the IRS at www.irs.gov.

A tendering Non-U.S. Shareholder who realizes a capital gain on a tender of Shares will generally not be subject to U.S. federal income tax on such gain, unless (i) the gain is effectively connected with the Non-US. Shareholder's conduct of a U.S. trade or business (and, if required under an applicable income tax treaty, is attributable to a U.S. permanent establishment) or (ii) the Non-U.S. Shareholder is an individual who is physically present in the United States for 183 days or more during the tax year and certain other conditions are satisfied. A tendering Non-U.S. Shareholder who realizes a capital gain may be eligible to claim a refund of any withheld tax by filing a U.S. tax return and demonstrating that it satisfies one of the provisions of Section 302 described above or is otherwise able to establish that no withholding or a reduced amount of withholding is due. Dividend income or capital gains that are effectively connected with a U.S. trade or business (and, if required under an applicable income tax treaty, are attributable to a U.S. permanent establishment) will generally be taxed on a net income basis at the same rates applicable to U.S. persons (and, in the case of a Non-U.S. Shareholder that is a corporation, may be subject to an additional branch profits tax at the rate of 30% (or lower rate provided by an applicable treaty)). Different rules may also apply in the case of certain Non-U.S. Shareholders that are subject to special rules, including former citizens or residents of the United States and "controlled foreign corporations." Non-U.S. Shareholders are advised to consult their own tax advisers.

<u>Backup Withholding and Certification Rules</u>. Non-U.S. Shareholders have special U.S. tax certification requirements to avoid backup withholding at a rate of 24%, and if applicable, to obtain the benefit of any income

------

##### [**Table of Contents**](#toc)
tax treaty between the Non-U.S. Shareholder's country of residence and the United States. To claim these tax benefits, the non-U.S. Shareholder must provide the Transfer Agent with a properly completed IRS Form W-8BEN or W-8BEN-E (or other IRS Form W-8, where applicable, or their substitute forms) to establish his or her status as a Non-U.S. Shareholder, to claim beneficial ownership over Shares, and to claim, if applicable, a reduced rate of or exemption from withholding tax under the applicable treaty. Backup withholding generally will not apply to amounts subject to the 30% or a treaty-reduced rate of withholding.

<u>FATCA Withholding</u>. A Non-U.S. Shareholder (other than an individual) may be subject to a 30% withholding tax under FATCA unless such Non-U.S. Shareholder establishes an exemption from such withholding tax under FATCA, typically on IRS Form W-8BEN-E. Amounts withheld under FATCA will be credited against any withholding due for U.S. federal income tax. Non-U.S. Shareholders are encouraged to consult with their tax advisers regarding the possible implications of these rules on their participation in the Offer.

**Non-U.S. Shareholders are urged to consult their own tax advisers regarding the application of U.S. federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.** 

**The U.S. federal income tax discussion set forth above is a summary included for general information purposes only. In view of the individual nature of tax consequences, each shareholder is advised to consult its own tax adviser with respect to the specific tax consequences to it of the Offer, including the effect and applicability of state, local, foreign and other tax laws and the possible effects of changes in federal or other tax laws.** 

**14.** **Certain Legal and Regulatory Matters.** 

The Trust is not aware of any approval or action by any government or governmental, administrative or regulatory authority or agency, domestic or foreign, that would be required to effect the Offer. Should any such approval or other action be required, the Trust presently contemplates that such approval or other action will be sought. The Trust is unable to predict whether it may determine that it is required to delay the acceptance for payment of, or payment for, Shares purchased pursuant to the Offer pending the outcome of any such matter. There can be no assurance that any such approval or other action, if needed, would be obtained without substantial conditions or that the failure to obtain any such approval or other action might not have a material adverse effect on the Trust. The Trust's obligations under the Offer to accept for payment and pay for Shares are subject to certain conditions described in Section 4, "Certain Conditions of the Offer."

**15.** **Amendments; Extensions of Purchase Period; Termination.** 

Subject to the applicable rules and regulations of the Commission, the Trust expressly reserves the right, in its sole discretion, at any time and from time to time, to extend the period during which the Offer is open for any reason, including the failure to satisfy any of the conditions specified in Section 4, and thereby delay acceptance for payment of, and payment for, any Shares, by giving oral or written notice of such extension to the Transfer Agent and by making a public announcement thereto. There can be no assurance that the Trust will exercise its right to extend the Offer. During any such extension, all Shares previously tendered and not properly withdrawn will remain subject to the Offer, subject to the rights of a tendering shareholder to withdraw such shareholder's Shares. See Section 6, "Withdrawal Rights."

Subject to the applicable rules and regulations of the Commission, the Trust also expressly reserves the right, in its sole discretion, at any time and from time to time, to: (a) terminate the Offer and not accept for payment (or pay for) any Shares if any of the conditions referred to in Section 4 has not been satisfied or upon the occurrence and during the continuance of any of the events specified in Section 4; and (b) waive any condition or amend the Offer in any respect, in each case by giving oral or written notice of termination, waiver

------

##### [**Table of Contents**](#toc)
or amendment to the Transfer Agent and by making a public announcement thereof. The Trust acknowledges that Rule 14e-1(c) under the Exchange Act requires the Trust to pay the consideration offered or return the Shares tendered for purchase promptly after the termination or withdrawal of the Offer, and that the Trust may not delay acceptance or payment for any Shares upon the occurrence of any of the conditions specified in Section 6 without extending the period during which the Offer is open.

Any extension, termination or amendment will be followed as promptly as practicable by a public announcement thereof, such announcement, in the case of an extension, to be made no later than 9:00 a.m., Eastern time, on the next business day after the previously scheduled expiration date. Without limiting the manner in which the Trust may choose to make any public announcement, except as provided by applicable law (including Rules 13e-4(c), 13e-4(e) and 14e-1 under the Exchange Act, which require that material changes be promptly disseminated to holders of Shares), the Trust will have no obligation to publish, advertise or otherwise communicate any such public announcement other than by issuing a press release and filing such release with the Commission.

If the Trust makes a material change in the terms of the Offer or the information concerning the Offer, or waives a material condition of the Offer, the Trust will disseminate additional Offer materials and extend the Offer to the extent required by Rules 13e-4(e) and 13e-4(f) under the Exchange Act. The minimum period during which the Offer must remain open following material changes in the terms of the Offer or information concerning the Offer, other than a change in price or a change in percentage of securities sought, will depend upon the facts and circumstances, including the materiality of the changes. With respect to a change in price or, subject to certain limitations, a change in the percentage of securities sought, a minimum ten business day period from the date of such change is generally required to allow for adequate dissemination of such change to shareholders. Accordingly, if, for example, prior to the Expiration Date, the Trust decreased the number of Shares being sought, increased the consideration offered pursuant to the Offer or added a dealer's soliciting fee, and if the Offer were scheduled to expire at any time earlier than the tenth business day from the date that notice of such increase, decrease or addition is first published, sent or given to shareholders, the Offer would be extended until at least the expiration of such ten business day period. For purposes of the Offer, a "business day" means any day other than a Saturday, Sunday or a U.S. federal holiday and consists of the time period from 12:01 a.m. through midnight Eastern time.

**16.** **Fees and Expenses.** 

The Trust will not pay to any broker or dealer, commercial bank, trust company or other person any solicitation fee for any Shares purchased pursuant to the Offer. The Trust will reimburse these firms for customary handling and mailing expenses incurred in forwarding the Offer. No broker, dealer, commercial bank or trust company has been authorized to act as the agent of the Trust or the Transfer Agent for purposes of the Offer.

**17.** **Miscellaneous.** 

The Offer is not being made to, nor will the Trust accept tenders from, or on behalf of, owners of Shares in any jurisdiction in which the making of the Offer or its acceptance would not comply with the securities or "blue sky" laws of that jurisdiction. The Trust is not aware of any jurisdiction in which the making of the Offer or the acceptance of tenders of, purchase of, or payment for, Shares in accordance with the Offer would not be in compliance with the laws of such jurisdiction. The Trust, however, reserves the right to exclude shareholders in any jurisdiction in which it is asserted that the Offer cannot lawfully be made or tendered Shares cannot lawfully be accepted, purchased or paid for. So long as the Trust makes a good-faith effort to comply with any state law deemed applicable to the Offer, the Trust believes that the exclusion of shareholders residing in any such jurisdiction is permitted under Rule 13e-4(f)(9) promulgated under the Exchange Act. In any jurisdiction where the securities, blue sky or other laws require the Offer to be made by a licensed broker or dealer, the Offer shall be deemed to be made on the Trust's behalf by one or more brokers or dealers licensed under the laws of such jurisdiction.

------

##### [**Table of Contents**](#toc)
**FINANCIAL STATEMENTS** 

The audited annual financial statements of the Trust dated December 31, 2021 and the schedule of investments of the Trust dated December 31, 2021, both filed with the SEC on EDGAR on Form N-CSR on March 4, 2022, are incorporated by reference. The unaudited semi-annual financial statements of the Trust dated June 30, 2022 and the schedule of investments of the Trust dated June 30, 2022, both filed with the SEC on EDGAR on Form N-CSR on September 1, 2022, are incorporated by reference. The Trust will prepare and transmit to shareholders the audited annual financial statements of the Trust and the schedule of investments of the Trust within 60 days after the close of the period for which the report is being made, or as otherwise required by the 1940 Act.

------

##### [**Table of Contents**](#toc)
The Tender Request Form and any other required documentation should be sent or delivered by each shareholder or the shareholder's broker, dealer, commercial bank, trust company or other nominee to the Transfer Agent at one of the addresses set forth below.

*The Transfer Agent for the Offer* 

*is:* 

**BNY Mellon Investment Servicing (US) Inc.** 

---

| | |
|:---|:---|
| *Written* |  |
| *Correspondence:* | *By Overnight Mail:* |
| P.O. Box 9819 | 4400 Computer Drive |
| Providence, Rhode Island 02940-8019 | Westborough, Massachusetts 01581 |

---

**For additional questions or information during the pendency of this Offer, you may contact your financial** 

**adviser, broker/dealer or other financial intermediary which holds your shares. If your account is held** 

**directly at BlackRock, you may contact the Trust at 1-800-882-0052, Option 4.** 

January 9, 2023

OTP_XMSAX_0123

## Ex-99.(A)(1)(Ii)

**Exhibit (a)(1)(ii)** 

---

| | |
|:---|:---|
|  ![LOGO](g419816g33p01.jpg)  | BlackRock Multi-Sector Opportunities Trust II Tender Request Form |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;Use this form to request a Tender of shares of the BlackRock Multi-Sector Opportunities Trust II **only** if your account is held at BlackRock. | Send this form, along with any other required documents, to: | Send this form, along with any other required documents, to: |
| &nbsp;&nbsp;&nbsp;&nbsp; <br> ![LOGO](g419816g33p02.jpg) Certain requests, including amounts in excess of $100,000, may require a Medallion Signature Guarantee stamp | <br> ![LOGO](g419816g33p03.jpg) **Regular mail:**<br> BlackRock Funds<br> P.O. Box 9819<br> Providence, RI 02940 | <br> ![LOGO](g419816g33p03.jpg) **Overnight mail:**<br> BlackRock Funds<br> 4400 Computer Drive<br> Westborough, MA 01581 |
|  | <br> **Fax: (844) 569-5573** | <br> **Fax: (844) 569-5573** |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p04.jpg) | **Questions?** Call us at **1-800-882-0052, Option 4**, Monday through Friday between 8:00 AM and 6:00 PM ET or online at <u>www.blackrock.com</u>. |

---

------

**BlackRock employees, board members and their immediate family members** who have an account held directly at BlackRock would use this form to request a tender of shares of the BlackRock Multi-Sector Opportunities Trust II (the "Fund") pursuant to a quarterly tender offer. Contact your financial professional or brokerage if your account is not held at BlackRock (check your account statement if you are unsure where your account is).

**This form must be RECEIVED by BNY Mellon Investment Servicing (US), Inc. no later than 4:00 p.m. Eastern Time on the expiration date. Tender requests received by BNY Mellon Investment Servicing (US), Inc. cannot be revoked after the expiration date unless shares have not been accepted for payment by 4:00 p.m. on March 8, 2023, after which a tender request may be revoked.** 

**Requests received for future tender periods or outside of an active tender period will be returned.** 

A fax copy of this request may be accepted, unless a signature stamp (i.e. notary or medallion signature guarantee stamp) is required.

Review the Offer to Purchase for additional details, however if you have any questions we encourage you to call us at **1-800-882-0052, Option 4** or email our team at <u>contact.us@blackrock.com.</u>

**1. Current Account Information** 

Please tell us about the account(s) that you wish to withdraw from:

---

| | |
|:---|:---|
|  <u> </u><br> Full name of account owner, custodian, trustee, etc.<br><u> </u><br> Full name of joint owner, minor, co-trustee, etc.<br><u> </u><u> </u><br> Social Security Number BlackRock Account Number(s) | <u> </u><br> Contact telephone number<br><u> </u><br> Contact telephone number<br><u> </u><br> Reference number (if applicable) |

---

**2. Shares to be Tendered for Tender** 

☐ Please Tender ALL shares in the account(s) referenced in section 1. Proceed to **Section 4.** 

☐ I request a Partial Tender of shares in the accounts referenced in section 1 so that I may receive the amount indicated below: 

---

| | |
|:---|:---|
| **Account Number:** |  |
| <u> </u> | $<u> </u> |
| <u> </u> | $<u> </u> |

---

------

**3a. For IRA (Individual Retirement Accounts) ONLY** 

To help ensure your distribution is processed correctly and is reported to the IRS properly, please complete this section to tell us more about the type of distribution.

☐ **Normal Distribution from Traditional, Rollover, SEP, or SIMPLE IRA –** You are over the age of 59 <sup>1</sup>⁄<sub>2</sub> 

☐ **Roth IRA Distributions:** You are over 59 <sup>1</sup>⁄<sub>2</sub> and this Distribution satisfies the 5-year holding period requirement. (If "No", then please check the applicable box below. These distributions will be considered premature if they are not due to disability.) 

☐ **Early (Premature) Distribution** – You are under the age of 59<sup>1</sup>⁄<sub>2</sub> (including distributions due to medical expenses, health insurance premiums, higher education expenses, first time homebuyer expenses, or other reasons). 

☐ **Inherited IRA Distribution** 

☐ **Permanent Disability** – You certify that you are disabled within the meaning of 72(m)(7) of the Internal Revenue Code (An individual shall be considered disabled if he/she is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or to be of long-continued and indefinite duration). 

☐ **Removal of excess contribution(s)** – Complete section 3b in its entirety. 

☐ **Direct Rollover to a qualified retirement plan, 401(k), TSP, 403(b), etc.** – You are certifying that the receiving custodian will accept the IRA assets issued. **(A Medallion Signature Guarantee will be required.)** 

☐ **Transfer Incident due to divorce or legal separation –** Additional Documentation or Medallion Signature Guarantee may be required. 

**3b. Return of Excess Contribution(s)** 

---

| | |
|:---|:---|
| Amount of Excess: $<u> </u> | Tax year in which the excess contribution was made:<u> </u> |
| Date deposited:<u> </u><br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date (mm/dd/yyyy) | Multiple deposits between:<u> </u> and<u> </u><br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date (mm/dd/yyyy) Date (mm/dd/yyyy) |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | Earnings will be removed with the excess contribution if corrected before your federal income tax-return due date (including extensions), pursuant to Internal Revenue Code Section 408(d)(4) and Internal Revenue Service ("IRS") Publication 590. You may be subject to an IRS penalty of 6% for each year the excess remains in the account. In addition, the IRS may impose a 10% early distribution penalty on the earnings, if you are under age 59<sup>1</sup>⁄<sub>2</sub>.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | You will receive IRS Form 1099-R for the year in which the excess distribution takes place (not for the year in which the excess contribution was made). Consult IRS Publication 590 for more information pertaining to excess contributions. If you are subject to a federal penalty tax due to an excess contribution, you must file IRS Form 5329.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | For the purpose of the excess contribution, we will calculate the net income attributable ("NIA") to the contribution using the method provided in the IRS Final Regulations for Earnings Calculation for Returned or Re-characterized Contributions. This method calculates the NIA based on the actual earnings and losses of the IRA during the time it held the excess contribution. Please note that a negative NIA is permitted and, if applicable, will be deducted from the amount of the excess contribution.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | **Re-designating an excess contribution to a later tax year**. Please consult a tax advisor to review your specific situation and to determine your best course of action. If you should decide to carry over the excess contribution to a later year, DO NOT RETURN THIS FORM.  |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **A) The excess is being corrected before your federal income tax-filing deadline (including extensions):**<br>☐ Remove excess plus/minus net income attributable. Distribute according to instructions in **Section 3b**.<br>☐ Remove excess plus/minus net income attributable. Re-deposit as a current year contribution (not to exceed annual IRA contribution limit). | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **B) The excess is being corrected after your federal income tax-filing deadline (including extensions). Earnings on the excess will remain in the account.**<br>☐ Remove excess and distribute according to instructions in **Section 3b.**<br>☐ Remove excess and re-deposit as a current year contribution (not to exceed annual IRA contribution limit). |

---

Section 3c, "Tax WITHHOLDING Election" on the next page, must be completed for ***all*** IRA withdrawals.

---

| | |
|:---|:---|
| *BlackRock Tender Request Form* | Page **2** of **4** |

---

------

**3c. Tax Withholding Election (REQUIRED)** 

Distributions from IRAs and qualified retirement plans that are not eligible for rollover are subject to federal income tax withholding and may be subject to state withholding. You may affirmatively elect additional withholding or opt to NOT have withholding applied to your distributions. Federal tax withholding is required for accounts with a foreign address. Please consult a tax professional or your state's tax authority for additional information on your state requirements.

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | **Federal Tax Withholding**  |

---

Federal income tax withholding is taken on any distribution, subject to the IRS withholding rules, at the rate of 10% from the gross payment amount even if it is excluded from gross income, unless an election is provided. The withholding procedure may result in excess payments to the IRS. Electing to have no federal taxes withheld from distributions or not having enough federal income tax withheld from distributions may cause you to be responsible for estimated tax. Under the estimated tax rules you may incur penalties if the estimated tax withholding payment is not sufficient. Please complete the section below, your election will remain in effect until the Custodian is notified in writing of a change.

Select one of the following:

---

| | | |
|:---|:---|:---|
| ☐ I elect **NOT** to withhold federal income tax | ☐ Withhold<u> </u>% federal income tax | ☐ Withhold 10% federal income tax |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | **State Withholding**  |

---

State income tax withholding requirements are determined by the state of your residence, if any. States with mandatory withholding may require state income tax to be withheld if withholding is taken for federal taxes or may mandate a fixed amount regardless of your federal tax election. Voluntary states allow you to determine if you would like state taxes withheld. Certain states are non-participatory and do not require income tax on retirement payments.

---

| | |
|:---|:---|
| For Mandatory States Only: | For Voluntary States Only: |
| ☐ I elect NOT to withhold state income Tax | ☐ Withhold $<u> </u> or<u> </u>% state income tax |

---

**4. Delivery Instructions** 

Please check the appropriate box to tell us where to send your distribution. Please note: Certain requests may require a Medallion Signature Guarantee stamp and additional documentation (such as a death certificate).

---

| | | |
|:---|:---|:---|
| ☐ Send the proceeds by check to the owner(s)'s address by: | ☐ Regular Mail **OR** | ☐ Overnight ($15 fee) |
| ☐ Send the proceeds to my existing bank account on record by: | ☐ ACH | ☐ Wire ($7.50 per fund) |
| &nbsp;&nbsp;&nbsp;&nbsp; **(Bank Instructions must be on file at BlackRock)** |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Send the proceeds to my *new* bank instructions **(Complete below)**<br> **(Medallion Stamp REQUIRED)**<br>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Complete this section below and **attach a bank statement, voided check, or savings deposit slip**  | &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Complete this section below and **attach a bank statement, voided check, or savings deposit slip**  | &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Complete this section below and **attach a bank statement, voided check, or savings deposit slip**  |
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(showing the bank account number & registration of your bank account). | &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(showing the bank account number & registration of your bank account). | &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(showing the bank account number & registration of your bank account). |
| &nbsp;&nbsp;&nbsp;&nbsp; ☐ Transfer Funds Electronically (ACH)<br>| **OR** | ☐ Wire Funds ($7.50 per fund) |
|  |  | <u> </u> |
|  Full name of bank account owner |  | Name of bank |
|  |  | ☐ Checking ☐ Savings<br><u> </u><u> </u><br> ABA routing number (9 digits) Bank account number |
|  Full name of joint bank account owner |  | ☐ Checking ☐ Savings<br><u> </u><u> </u><br> ABA routing number (9 digits) Bank account number |
| <br> <u> </u> |  | ☐ Checking ☐ Savings<br><u> </u><u> </u><br> ABA routing number (9 digits) Bank account number |
|  Signature of other bank account owner (if any) |  | ☐ Checking ☐ Savings<br><u> </u><u> </u><br> ABA routing number (9 digits) Bank account number |

---

**Please note:** If you do not select an option, your distribution will be mailed in the form of a check to your address of record. If you are planning to redeem via Federal Wire, please contact your bank to confirm whether or not they assess a fee upon receipt of the funds.

---

| | |
|:---|:---|
| *BlackRock Tender Request Form* | Page **3** of **4** |

---

------

**5. Signatures** 

**Please Note:** If you are redeeming to an address or bank account that does not match your BlackRock account, BlackRock will require a Medallion Signature Guarantee Stamp**.** If the stamp you obtain is not legible via fax, please mail it into the address on the upper right-hand corner of page one. If you cannot obtain a Medallion Signature Guarantee Stamp or have any additional questions, please speak with a BlackRock Service Center representative to assist you.

**I acknowledge that:** 

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | I certify that I am authorized to make these elections and that all information provided is true and accurate.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | No tax or legal advice has been given to me by the Custodian (BNY Mellon Asset Servicing, Inc.), the Fund, or any agent of either of them, and all decisions regarding the elections made on this form are my own.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | The Custodian is authorized to distribute funds from my account in the manner requested. The Fund may conclusively rely on this certification and authorization without further investigation or inquiry.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | I assume responsibility for any adverse consequences that may arise from the election(s) and agree that the Fund and their agents shall in no way be responsible, and shall be indemnified and held harmless, for any tax, legal or other consequences of the election(s) made on this form.  |

---

---

| | |
|:---|:---|
| ![LOGO](g419816g33p02.jpg) | The payment is to be sent to the registered owner(s) of the shares shown in the registration of the account.  |

---

---

| | | | |
|:---|:---|:---|:---|
|  ![LOGO](g419816g36p03.jpg)  |  |  |  |
|  | Signature of account owner, trustee, custodian, etc. <br>| Date (mm/dd/yyyy)<br>| Title / Capacity (if any)<br>|
| ![LOGO](g419816g36p03.jpg) |  |  |  |
|  | Signature of co-owner, trustee, custodian, etc. | Date (mm/dd/yyyy) | Title / Capacity (if any) |
| <br> **For Notary Public (if accepted):**<br>State of<u> </u> County of<u> </u> On this<u> </u> day of<u> </u>, 20<u> </u>, before me, the undersigned Notary Public,<u> </u>, personally appeared and proved through satisfactory evidence of Identification to be the person whose name is signed above and acknowledged by:<br><u> </u><br> Signature of Notary Public  | <br> **For Notary Public (if accepted):**<br>State of<u> </u> County of<u> </u> On this<u> </u> day of<u> </u>, 20<u> </u>, before me, the undersigned Notary Public,<u> </u>, personally appeared and proved through satisfactory evidence of Identification to be the person whose name is signed above and acknowledged by:<br><u> </u><br> Signature of Notary Public  | ![LOGO](g419816g36p21.jpg) | ![LOGO](g419816g36p21.jpg) |
| <br> **For Notary Public (if accepted):**<br>State of<u> </u> County of<u> </u> On this<u> </u> day of <u>,</u> 20<u> </u>, before me, the undersigned Notary Public,<u> </u>, personally appeared and proved through satisfactory evidence of Identification to be the person whose name is signed above and acknowledged by:<br><u> </u><br> Signature of Notary Public  | <br> **For Notary Public (if accepted):**<br>State of<u> </u> County of<u> </u> On this<u> </u> day of <u>,</u> 20<u> </u>, before me, the undersigned Notary Public,<u> </u>, personally appeared and proved through satisfactory evidence of Identification to be the person whose name is signed above and acknowledged by:<br><u> </u><br> Signature of Notary Public  | ![LOGO](g419816g36p21.jpg) | ![LOGO](g419816g36p21.jpg) |

---

------

---

| | |
|:---|:---|
| **Not FDIC Insured \| May Lose Value \| No Bank Guarantee**<br> <sup>©</sup> 2023 BlackRock, Inc. All Rights Reserved. BLACKROCK is a registered trademark of BlackRock, Inc. or its subsidiaries in the United States and elsewhere. All other trademarks are those of their respective owners. | <br> ![LOGO](g419816g33p01.jpg)  |

---

**Lit. No. MSOII-REPURCH-0123** 

---

| | |
|:---|:---|
| *BlackRock Tender Request Form* | Page **4** of **4** |

---

## Ex-Filing

**EX-FILING FEES** 

**Calculation of Filing Fee Tables** 

**SC TO-I** 

(Form Type)

**BlackRock Multi-Sector Opportunities Trust II** 

(Exact Name of Registrant as Specified in its Charter)

**Table 1: Transaction Valuation** 

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction <br> Valuation | Fee<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rate  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount of <br> Filing Fee |
| &nbsp;&nbsp;&nbsp; Fees to Be Paid | $4361577.84(1) | 0.0001102% | $480.65(2) |
| &nbsp;&nbsp;&nbsp; Fees Previously Paid |  |  |  |
| &nbsp;&nbsp;&nbsp; **Total Transaction Valuation** | $4361577.84(1) |  |  |
| &nbsp;&nbsp;&nbsp; **Total Fees Due for Filing** |  |  | $480.65 |
| &nbsp;&nbsp;&nbsp; **Total Fees Previously Paid** |  |  |  |
| &nbsp;&nbsp;&nbsp; **Total Fee Offsets** |  |  |  |
| &nbsp;&nbsp;&nbsp; **Net Fee Due** |  |  | $480.65 |

---

------

(1) Calculated as the aggregate maximum purchase price for Shares that could be purchased, based upon the net asset
value of the Trust as of January 3, 2023.

(2) Calculated at $110.20 per $1,000,000 of the Transaction Value.